UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month November, 2026

Commission File Number 1-11414
BLADEX, INC.
(Translation of Registrant’s name into English)

Business Park Torre V, Ave. La Rotonda, Costa del Este
P.O. Box 0819-08730
Panama City, Republic of Panama
(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


BLADEX, INC.
(Registrant)
Date: November 12, 2026By:
/s/ Annette van Hoorde de Solís
Name:
Annette van Hoorde de Solís
Title:Chief Financial Officer
1









        

Bladex, Inc.
and Subsidiaries




Unaudited condensed consolidated interim financial statements as of September 30, 2026, and for the three and nine months ended September 30, 2026






















Bladex, Inc. and Subsidiaries









Contents

Condensed consolidated statement of financial position
Condensed consolidated statement of profit or loss
Condensed consolidated statement of comprehensive income
Condensed consolidated statement of changes in equity
Condensed consolidated statement of cash flows
Notes to the condensed consolidated interim financial statements (Unaudited)



2




Bladex, Inc. and Subsidiaries
Condensed consolidated statements of financial position
September 30, 2026 and December 31, 2025
(In thousands of US dollars)
September 30,
2026
December 31, 2025
Notes(Unaudited)(Audited)
Assets
Cash and due from banks3,4,51,841,669 1,923,731 
Investment securities3,4,61,821,093 1,428,990 
Loans3,4,712,321,300 9,141,668 
Customers' liabilities under acceptances3,4318,933 161,597 
Trading derivative assets3,4,931,587 1,569 
Hedging derivative financial instruments - assets3,4,978,888 69,837 
Equipment, right-of-use assets and leasehold improvements, net20,891 19,673 
Intangible assets9,277 10,744 
Other assets1036,335 28,584 
Total assets16,479,973 12,786,393 
Liabilities and Equity
Liabilities:
Customer deposits3,4,117,964,564 6,640,290 
Securities sold under repurchase agreements3,4,12248,514 130,509 
Borrowings and debt3,4,135,973,878 4,030,389 
Lease liabilities3,1418,962 18,429 
Acceptances outstanding3,4318,933 161,597 
Trading derivative liabilities3,4,926,305 433 
Hedging derivative financial instruments - liabilities3,4,973,623 62,506 
Provision for losses on loan commitments and financial guarantee contracts3,411,548 12,130 
Other liabilities1553,438 51,363 
Total liabilities14,689,765 11,107,646 
Equity:
Common stock279,980 279,980 
Treasury stock(91,028)(97,597)
Other equity instruments197,976 197,976 
Additional paid-in capital in excess of value assigned to common stock125,503 125,151 
Capital reserves2295,210 95,210 
Regulatory reserves22181,949 159,093 
Retained earnings987,029 916,429 
Other comprehensive income13,589 2,505 
Total equity1,790,208 1,678,747 
Total liabilities and equity16,479,973 12,786,393 
The accompanying notes are an integral part of these condensed consolidated interim financial statements (Unaudited).
3




Bladex, Inc. and Subsidiaries
Condensed consolidated statement of profit or loss
For the three and nine months ended September 30, 2026 and 2025
(In thousands of US dollars, except earnings per share data)
(Unaudited)
Three months ended September 30,Nine months ended September 30,
Notes2026202520262025
Interest income:
Deposits12,084 19,413 39,351 55,106 
Investment securities21,957 17,411 60,747 47,892 
Loans180,985 156,856 500,093 474,533 
Total interest income19215,026 193,680 600,191 577,531 
Interest expense:
Deposits(80,689)(75,177)(223,531)(217,563)
Securities sold under repurchase agreements12(2,082)(1,752)(5,922)(7,013)
Borrowings and debt13(52,286)(49,146)(146,935)(151,994)
Lease liabilities14(188)(178)(537)(539)
Total interest expense19(135,245)(126,253)(376,925)(377,109)
Net interest income79,781 67,427 223,266 200,422 
Other income:
Fees and commissions, net1816,299 14,052 52,764 44,547 
Gain on financial instruments, net182,971 882 4,832 5,027 
Other income1869 416 260 772 
Total other income, net1919,339 15,350 57,856 50,346 
Total revenues99,120 82,777 281,122 250,768 
Impairment losses on financial instruments3,19(10,412)(6,482)(23,745)(16,717)
Operating expenses:
Salaries and other employee expenses(16,139)(13,196)(43,441)(39,518)
Depreciation and amortization of equipment, right-of-use and leasehold improvements(937)(697)(2,764)(2,111)
Amortization of intangible assets(708)(355)(2,136)(1,029)
Other expenses(7,774)(7,079)(23,077)(20,509)
Total operating expenses19(25,558)(21,327)(71,418)(63,167)
Profit for the period63,150 54,968 185,959 170,884 
Per share data:
Basic earnings per share (in US dollars)171.48 1.48 4.56 4.60 
Weighted average basic shares (in thousands of shares)1737,597 37,231 37,521 37,126 

The accompanying notes are an integral part of these condensed consolidated interim financial statements (Unaudited).

4



Bladex, Inc. and Subsidiaries
Condensed consolidated statement of comprehensive income
For the three and nine months ended September 30, 2026 and 2025
(In thousands of US dollars)
(Unaudited)
Three months ended September 30,Nine months ended September 30,
2026202520262025
Profit for the period63,150 54,968 185,959 170,884 
Other comprehensive income
Items that can be subsequently reclassified as gains or losses
  Financial instruments measured at fair value
  through other comprehensive income (FVOCI)
  Changes in the fair value of debt instruments
  measured at FVOCI:
    Net fair value changes – Loans measured at
    FVOCI
6,169 717 7,146 319 
    Net changes in fair value – Investment securities
    measured at FVOCI
(6,744)2,685 (2,834)2,797 
    Reclassifications to profit or loss – Loans
    measured at FVOCI
— (485)(75)(638)
    Reclassifications to profit or loss – Investment
    securities measured at FVOCI
— (475)(125)(563)
    Total changes in the fair value of debt instruments
    measured at FVOCI
(575)2,442 4,112 1,915 
  Effects attributable to risk management
  Cash flow hedge reserve:
    Net changes in the effective portion of cash flow
    hedges
1,441 (330)7,930 3,361 
    Reclassifications from the cash flow hedge reserve
    to profit or loss
304 122 415 (1,188)
    Total cash flow hedge reserve1,745 (208)8,345 2,173 
 Deferred amounts for excluded components of
 hedging relationships
(280)33 (1,373)33 
Other comprehensive income890 2,267 11,084 4,121 
Total comprehensive income for the period64,040 57,235 197,043 175,005 

The accompanying notes are an integral part of these condensed consolidated interim financial statements (Unaudited).

5



Bladex, Inc. and Subsidiaries
Condensed consolidated statement of changes in equity
For the nine months ended September 30, 2026 and 2025
(In thousands of US dollars)
(Unaudited)
NoteCommon stockTreasury stockOther equity instrumentsAdditional paid-in capital in excess of value assigned to common stockCapital reservesRegulatory reservesRetained earningsOther comprehensive incomeTotal equity
Balances at January 1, 2025279,980 (105,601)124,970 95,210 149,666 792,005 979 1,337,209 
Profit for the period— — — — — — 170,884 — 170,884 
Other comprehensive income— — — — — — — 4,121 4,121 
Issuance of restricted stock (RSA)— 4,537 — (4,537)— — — — — 
Issuance of other equity instruments, net— — 197,976 — — — — — 197,976 
Compensation cost - stock units plans— — — 6,044 — — — — 6,044 
Stock units vested (RSU)— 3,483 — (3,483)— — — — — 
Regulatory credit reserve— — — — — 1,803 (1,803)— — 
Dividends declared— — — — — — (69,761)— (69,761)
Balances at September 30, 2025279,980 (97,581)197,976 122,994 95,210 151,469 891,325 5,100 1,646,473 
Balances at January 1, 2026279,980 (97,597)197,976 125,151 95,210 159,093 916,429 2,505 1,678,747 
Profit for the period— — — — — — 185,959 — 185,959 
Other comprehensive income— — — — — — — 11,084 11,084 
Issuance of restricted stock (RSA)— 3,822 — (3,822)— — — — — 
Compensation cost - stock units plans— — — 6,982 — — — — 6,982 
Stock units vested (RSU)— 2,808 — (2,808)— — — — — 
Repurchase of common stock— (61)— — — — — — (61)
Regulatory credit reserve— — — — — 259 (259)— — 
Dynamic provision— — — — — 22,597 (22,597)— — 
Dividends and coupons declared16— — — — — — (92,503)— (92,503)
Balances at September 30, 2026279,980 (91,028)197,976 125,503 95,210 181,949 987,029 13,589 1,790,208 

The accompanying notes are an integral part of these condensed consolidated interim financial statements (Unaudited).


6



Bladex, Inc. and Subsidiaries
Condensed consolidated statement of cash flows
For the nine months ended September 30, 2026 and 2025
(In thousands of US dollars)
(Unaudited)
Notes20262025
Cash flows from operating activities
Profit for the period185,959 170,884 
Adjustments to reconcile profit for the period to net cash (used in) provided by operating activities:
Depreciation and amortization of equipment, right-of-use and leasehold improvements2,764 2,111 
Amortization of intangible assets2,136 1,029 
Impairment losses on financial instruments323,745 16,717 
Realized gain on financial instruments18(338)(2,701)
Loss on derecognition of financial instruments at amortized cost18— 436 
Compensation cost - share-based payment6,982 6,044 
Net changes in hedging position and foreign currency(20,882)128,832 
Loss on disposal of fixed assets and intangible assets6 6 
Interest income19(600,191)(577,531)
Interest expense19376,925 377,109 
Changes in operating assets and liabilities:
Restricted and pledged deposits20,257 70,916 
Loans(3,268,012)(622,713)
Proceeds from the sale of loans97,101 193,243 
Other assets(10,589)(20,450)
Due to depositors1,307,583 1,422,566 
Other liabilities830 2,743 
Cash flows (used in) provided by operating activities(1,875,724)1,169,241 
Interest received559,925 589,843 
Interest paid(367,588)(379,132)
Net cash (used in) provided by operating activities(1,683,387)1,379,952 
Cash flows from investing activities:
Acquisition of fixed assets and intangible assets(136)(168)
Acquisition of intangible assets— (1,260)
Proceeds from the sale of securities61,157 60,837 
Proceeds from the redemption of securities490,865 285,351 
Purchases of securities(943,495)(557,284)
Net cash used in investing activities(391,609)(212,524)
Cash flows from financing activities:
Increase (decrease) in securities sold under repurchase agreements117,468 (73,672)
Net increase (decrease) in short-term borrowings and debt131,654,461 (609,454)
Proceeds from long-term borrowings and debt13735,711 319,580 
Payments of long-term borrowings and debt13(402,611)(866,901)
Issuance of other equity instruments16— 197,976 
Payments of lease liabilities14(1,136)(852)
Dividends and coupons paid(91,260)(68,908)
Repurchase of common stock(61)— 
Net cash provided by (used in) financing activities2,012,572 (1,102,231)
Net (decrease) increase in cash and cash equivalents(62,424)65,197 
Cash and cash equivalents at beginning of the period1,842,208 1,819,931 
Cash and cash equivalents at end of the period51,779,784 1,885,128 
The accompanying notes are an integral part of these condensed consolidated interim financial statements (Unaudited).
7

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
1.Corporate information

Bladex, Inc. (the "Parent Company" and, together with its subsidiaries, "Bladex" or the "Bank"), domiciled in Panama City, Republic of Panama, is a multinational bank established to support foreign trade financing and economic integration throughout Latin America and the Caribbean (the "Region").

The Bank was established in May 1975, pursuant to a proposal submitted to the Assembly of Governors of Central Banks of the Region, which recommended the creation of a multinational organization to enhance the Region's foreign trade financing capacity. The Bank was organized in 1977, incorporated in 1978 under the laws of the Republic of Panama, and commenced business operations on January 2, 1979. Pursuant to a law contract entered into between the Republic of Panama and the Bank in 1978, the Bank was granted certain privileges, including an exemption from income taxes in Panama.

On April 21, 2026, the Bank's shareholders approved an amendment to Article 1 of the Bank's Articles of Incorporation to change the Bank's corporate name. The amendment became effective on June 4, 2026, changing the Bank's legal name from "Banco Latinoamericano de Comercio Exterior, S.A." in Spanish and "Foreign Trade Bank of Latin America, Inc." in English to "Bladex, Inc.", with no change to the Bank's legal existence or corporate structure. Accordingly, this change in corporate name did not affect the Bank's operations, ownership structure, financial position, or reporting entity. These consolidated financial statements are therefore presented under the Bank's new legal name, "Bladex, Inc. and Subsidiaries."
The Bank operates under a general banking license issued by the National Banking Commission of Panama, predecessor of the Superintendence of Banks of Panama (the “SBP”).
In the Republic of Panama, banks are regulated by the SBP through Executive Decree No. 52 of April 30, 2008, which adopts the unique text of Law Decree No. 9 of February 26, 1998, modified by Law Decree No. 2 of February 22, 2008. Banks are also regulated by resolutions and agreements issued by this entity. The main aspects of this law and its regulations include: the authorization of banking licenses, minimum capital and liquidity requirements, consolidated supervision, procedures for management of credit, liquidity and market risks, measures to prevent money laundering, the financing of terrorism and related illicit activities, and procedures for banking intervention and liquidation, among others.
Bladex Head Office’s subsidiaries are the following:
-    Bladex Holdings Inc. is a wholly owned subsidiary, incorporated under the laws of the State of Delaware, United States of America (USA), on May 30, 2000. Bladex Holdings Inc. has ownership in Bladex Representaçao Ltda.
-    Bladex Representaçao Ltda, incorporated under the laws of Brazil on January 7, 2000, acts as the Bank’s representative office in Brazil. Bladex Representaçao Ltda. is 99.999% owned by Bladex Head Office and the remaining 0.001% is owned by Bladex Holdings Inc.
-    Bladex Development Corp. was incorporated under the laws of the Republic of Panama on June 5, 2014. Bladex Development Corp. is 100.00% owned by Bladex Head Office.
Bladex Head Office has an agency in New York City, USA (the “New York Agency”), which began operations on March 27, 1989. The New York Agency is principally engaged in financing transactions related to international trade, mostly the confirmation and financing of letters of credit for customers in the Region. The New York Agency also has authorization to book transactions through an International Banking Facility (“IBF”).
The Bank has representative offices in Buenos Aires, Argentina; in Mexico City, Mexico; and in Bogota, Colombia, and has a representative license in Lima, Peru.






8

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
2. Basis of preparation and changes to the Bank’s accounting policies
2.1 Basis of preparation
These interim condensed consolidated financial statements for the period ended September 30, 2026 have been prepared in accordance with International Accounting Standards IAS 34 “Interim Financial Reporting”. The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board ("IFRS Accounting Standards") and should be read in conjunction with the Bank’s annual consolidated financial statements as at and for the year ended December 31, 2025.

These interim financial statements were authorized for issue by the Bank’s board of directors on October 20, 2026.
2.2. Accounting Standards Issued but Not Yet in Effect
IFRS 18 – Presentation and Disclosure in Financial Statements will replace IAS 1: Presentation of Financial Statements and will be applicable for annual periods beginning on or after January 1, 2027. The Bank has not adopted this standard early in the preparation of these interim financial statements.
IFRS 18 introduces changes to the structure of the income statement, greater disaggregation of financial information, and new disclosures related to performance measures defined by management. The Bank is in the process of evaluating the impact of its adoption, which may vary as the implementation of changes to accounting processes, controls, and policies is finalized.
In general terms, the following impacts are expected:
•Structure of the income statement: Income and expenses will be classified into categories such as operating, investing, and financing activities, among others. Since the Bank qualifies as an entity whose primary activity is providing financing, interest income and expenses will be presented within the operating category, eliminating their current presentation as a separate subtotal. New defined subtotals will also be introduced, such as operating profit and profit before financing and taxes.
•Classification of income and expenses: Certain items, including exchange differences, hedging instruments, and other income, will be reclassified according to the nature of the items that generate them. Additionally, the share of the results of investments accounted for using the equity method will be presented within the investment category.
•Performance measures defined by management: The Bank is in the process of developing the framework for identifying and disclosing these measures, which will be based on public communications and aligned with the financial statement reporting period.
•Aggregation and disaggregation: Greater disaggregation of items in the financial statements and notes is expected, including a review of items currently presented as “other.”
•Cash flows: Operating profit will be used as the starting point for presenting operating cash flows under the indirect method. The classification of cash flows related to interest and dividends will also be adjusted in accordance with IFRS 18 requirements.
















9

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review

This note presents information about the Bank’s exposure to financial risks:

A.Credit risk

i.Credit quality analysis

The following tables set out information about the credit quality of financial assets measured at amortized cost, and debt instruments at FVOCI. For loan commitments and financial guarantee contracts, the amounts in the table represent the amounts committed or guaranteed, respectively.

Deposits

September 30, 2026
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 4
0.05 - 0.28
1,840,980 — — 1,840,980 
Grades 5 - 6
0.29 - 3.60
658 — — 658 
Grades 7 - 8
3.61 - 36.40
67 — — 67 
1,841,705 — — 1,841,705 
Allowance for credit losses(36)— — (36)
Total1,841,669 — — 1,841,669 

December 31, 2025
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 4
0.05 - 0.38
1,923,151 — — 1,923,151 
Grades 5 - 6
0.39 - 3.81
660 — — 660 
Grades 7 - 8
3.82 - 34.52
75 — — 75 
1,923,886 — — 1,923,886 
Allowance for credit losses(155)— — (155)
Total1,923,731 — — 1,923,731 

Loans, at amortized cost (1)
September 30, 2026
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 40.05 - 0.287,152,687 — — 7,152,687 
Grades 5 - 60.29 - 3.603,867,307 53,359 3,920,666 
Grades 7 - 83.61 - 36.40334,956 23,814 45,609 404,379 
Grades 9 - 1036.41 - 100— — 31,825 31,825 
11,354,950 77,173 77,434 11,509,557 
Allowance for credit losses(33,570)(7,248)(46,092)(86,910)
Total11,321,380 69,925 31,342 11,422,647 





10

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A.Credit risk (continued)

December 31, 2025
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 40.05 - 0.38 5,399,585 — — 5,399,585 
Grades 5 - 60.39 - 3.813,412,140 78,892 — 3,491,032 
Grades 7 - 83.82 - 34.52125,507 102,127 — 227,634 
Grades 9 - 1034.53 - 100— — 39,985 39,985 
8,937,232 181,019 39,985 9,158,236 
Allowance for credit losses(31,660)(33,169)(28,979)(93,808)
Total8,905,572 147,850 11,006 9,064,428 



Loans at FVOCI (1)

September 30, 2026
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 4
0.05 - 0.28
706,101 — — 706,101 
Grades 5 - 6
0.29 - 3.60
161,312 — — — 161,312 
Grades 7 - 8
3.61-36.40
31,240 — — 31,240 
898,653 — — 898,653 
Allowance for credit losses(3,958)— — (3,958)

December 31, 2025
PD RangesStage 1Stage 2Stage 3Total
Grades 1 - 40.05 - 0.3815,627 — — 15,627 
Grades 5 - 60.39 - 3.8161,613 — — 61,613 
77,240 — — 77,240 
Allowance for credit losses(468)— — (468)

(1) Loans at amortized cost and FVOCI include interest and commission receivable.














11

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A.Credit risk (continued)

Loan commitments, financial guarantees issued and customers’ liabilities under acceptances
September 30, 2026
PD RangesStage 1Stage 2Total
Commitments and contingencies
Grades 1 - 40.05 - 0.281,060,406 — 1,060,406 
Grades 5 - 60.29 - 3.60932,216 2,880 935,096 
Grades 7 - 83.61 - 36.40143,025 2,692 145,717 
2,135,647 5,572 2,141,219 
Customers' liabilities under acceptances
Grades 1 - 40.05 - 0.2889,851 — 89,851 
Grades 5 - 60.29 - 3.60229,082 — 229,082 
318,933 — 318,933 
2,454,580 5,572 2,460,152 
Provision(10,996)(552)(11,548)
Total2,443,584 5,020 2,448,604 

December 31, 2025
PD RangesStage 1Stage 2Total
Commitments and contingencies
Grades 1 - 40.05 - 0.38876,482 — 876,482 
Grades 5 - 60.39 - 3.81676,044 365 676,409 
Grades 7 - 83.82 - 34.52287,766 — 287,766 
1,840,292 365 1,840,657 
Customers' liabilities under acceptances
Grades 1 - 40.05 - 0.3864,761 — 64,761 
Grades 5 - 60.39 - 3.8131,284 — 31,284 
Grades 7 - 83.82 - 34.5265,552 — 65,552 
161,597 — 161,597 
2,001,889 365 2,002,254 
Provision(12,128)(2)(12,130)
Total1,989,761 363 1,990,124 












12

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A.Credit risk (continued)
Securities at amortized cost(1)
September 30, 2026
PD RangesStage 1Stage 2Total
Grades 1 - 4
0.05 - 0.28
1,441,921 — 1,441,921 
1,441,921 — 1,441,921 
Allowance for credit losses(441)— (441)
Total1,441,480 — 1,441,480 

December 31, 2025
PD RangesStage 1Stage 2Total
Grades 1 - 40.05 - 0.381,294,293 — 1,294,293 
Grades 5 - 60.39 - 3.8155,550 10,654 66,204 
1,349,843 10,654 1,360,497 
Allowance for credit losses(918)(65)(983)
Total1,348,925 10,589 1,359,514 
Securities at FVOCI(1)
September 30, 2026
PD RangesStage 1Stage 2Total
Grades 1 - 40.05 - 0.2889,852 318,933 $—408,785 
Grades 5 - 6
0.29 - 3.60
229,082 — 229,082 
318,934 318,933 637,867 
Allowance for credit losses - FVOCI(727)— (552)(727)
December 31, 2025
PD RangesStage 1Stage 2Total
Grades 1 - 40.05 - 0.3869,476 — 69,476 
Allowance for credit losses - FVOCI(16)— (16)

(1) Securities at amortized cost and FVOCI include interest receivable.

The allowance for credit losses for loans and investment securities at FVOCI do not affect the carrying value of the assets. These allowances are included in the equity in the consolidated statement of financial position in the line Other comprehensive income.

The following table presents information of the current and past due balances of loans:
September 30,
2026
December 31, 2025
Current12,325,595 9,195,491 
Past due (1)
82,615 39,985 
Total12,408,210 9,235,476 

(1) Past due loans are classified in Stage 2 and Stage 3.

13

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

The following table presents an analysis of counterparty credit exposures arising from derivative transactions. The Bank's derivatives are generally collateralized by cash.

September 30, 2026
Notional value
USD
Derivative
financial
instruments -
fair value asset
Derivative
financial
instruments -
fair value
liabilities
Interest rate swaps2,881,094 42,834 (39,915)
Cross-currency swaps2,153,460 66,927 (59,398)
Foreign exchange forwards32,245 714 (615)
Total5,066,799 110,475 (99,928)
December 31, 2025
Notional value
USD
Derivative
financial
instruments -
fair value asset
Derivative
financial
instruments -
fair value
liabilities
Interest rate swaps1,754,481 27,644 (5,868)
Cross-currency swaps1,317,295 43,762 (57,027)
Foreign exchange forwards7,039 — (44)
Total3,078,815 71,406 (62,939)

ii.Allowance for credit losses

The following tables show reconciliations from the opening to the closing balance of the Allowance for credit losses by class of financial instrument.

Bank deposits
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 2025155 — — 155 
Net effect of changes in allowance for expected credit losses(10)— — (10)
Financial instruments that have been derecognized during the period(126)— — (126)
New financial assets originated or purchased17 — — 17 
Impairment losses on financial instruments(119)— — (119)
Allowance for expected credit losses as of September 30, 202636 — — 36 








14

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 2024— — — — 
Net effect of changes in allowance for expected credit losses155 — — 155 
Impairment losses on financial instruments155 — — 155 
Allowance for expected credit losses as of December 31, 2025155 — — 155 
Loans at amortized cost
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 202531,660 33,169 28,979 93,808 
Transfer to lifetime expected credit losses(240)240 — — 
Transfer to credit-impaired financial instruments— (14,147)14,147 — 
Net effect of changes in allowance for expected credit losses(5,972)9,841 11,568 15,437 
Financial instruments that have been derecognized during the period(14,855)(21,860)— (36,715)
New financial assets originated or purchased22,977 5 — 22,982 
Write-offs— — (8,602)(8,602)
Allowance for expected credit losses as of September 30, 202633,570 7,248 46,092 86,910 

Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 202445,635 20,040 12,483 78,158 
Transfer to lifetime expected credit losses(176)(10,151)10,327 — 
Net effect of changes in allowance for expected credit losses(2,762)14,536 6,169 17,943 
Financial instruments that have been derecognized during the year(35,330)(6,640)— (41,970)
New financial assets originated or purchased24,293 15,384 — 39,677 
Allowance for expected credit losses as of December 31, 202531,660 33,169 28,979 93,808 











15

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

The following table provides a reconciliation between:

•The items shown in the table above that reconcile the beginning and ending balances of the provision for expected credit losses on amortized cost loans; and
•The item Impairment losses on financial instruments, presented in the consolidated statement of profit or loss.
September 30,
2026
September 30,
2025
Net effect of changes in allowance for expected credit losses(828)(28,683)
New financial assets originated or purchased22,982 37,162 
Recoveries of amount previously written off(1,367)— 
Impairment losses on financial instrument recognised in profit or loss20,787 8,479 
Loans at FVOCI
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 2025468 — — 468 
Net effect of changes in allowance for expected credit losses(76)— — (76)
Financial instruments that have been derecognized during the period(94)— — (94)
New financial assets originated or purchased3,660 — — 3,660 
Impairment losses on financial instruments3,490 — — 3,490 
Allowance for expected credit losses as of September 30, 20263,958 — — 3,958 
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 2024— — — — 
New financial assets originated or purchased468 — — 468 
Impairment losses on financial instruments468 — — 468 
Allowance for expected credit losses as of December 31, 2025468 — — 468 












16

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Loan commitments, financial guarantee contracts and customers’ liabilities under acceptances

The allowance for expected credit losses on loan commitments and financial guarantee contracts reflects the Bank’s management estimate of expected credit losses of customers’ liabilities under acceptances and contingent liabilities such as: documentary letters of credit, stand-by letters of credit, guarantees, and credit commitments.

Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 202512,128 2 — 12,130 
Transfer to lifetime expected credit losses(18)18 — — 
Net effect of changes in reserve for expected credit losses(2,558)532 — (2,026)
Financial instruments that have been derecognized during the period(3,810)(2)— (3,812)
New instruments originated or purchased5,254 2 — 5,256 
Impairment losses on financial instruments(1,132)550 — (582)
Allowance for expected credit losses as of September 30, 202610,996 552 — 11,548 
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 20244,815 560 — 5,375 
Net effect of changes in reserve for expected credit losses(284)(5)— (289)
Financial instruments that have been derecognized during the year(3,369)(553)— (3,922)
New instruments originated or purchased10,966 — — 10,966 
Impairment losses on financial instruments7,313 (558)— 6,755 
Allowance for expected credit losses as of December 31, 202512,128 2 — 12,130 

Securities at amortized cost
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 2025918 65 — 983 
Net effect of changes in allowance for expected credit losses(73)— — (73)
Financial instruments that have been derecognized during the period(552)(65)— (617)
New financial assets originated or purchased148 — — 148 
Impairment losses on financial instruments(477)(65)— (542)
Allowance for expected credit losses as of September 30, 2026441 — — 441 

17

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 20241,133 178 — 1,311 
Transfer to lifetime expected credit losses(19)19 — — 
Net effect of changes in allowance for expected credit losses(2)(85)— (87)
Financial instruments that have been derecognized during the year(387)— — (387)
New financial assets originated or purchased193 — — 193 
Impairment losses on financial instruments(215)(66)— (281)
Write-offs— (47)— (47)
Allowance for expected credit losses as of December 31, 2025918 65 — 983 

Securities at FVOCI
Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 202516 — — 16 
Financial instruments that have been derecognized during the year(13)— — (13)
New financial assets originated or purchased724 — — 724 
Impairment losses on financial instruments711 — — 711 
Allowance for expected credit losses as of September 30, 2026727 — — 727 

Stage 1Stage 2Stage 3Total
Allowance for expected credit losses as of December 31, 202423 — — 23 
Financial instruments that have been derecognized during the year(14)— — (14)
New financial assets originated or purchased7 — — 7 
Impairment losses on financial instruments(7)— — (7)
Allowance for expected credit losses as of December 31, 202516 — — 16 







18

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

The following table provides a summary of impairment losses on financial instruments presented in the consolidated statement of profit or loss:

September 30,
20262025
Cash and due from banks
(119)60 
Loans at amortized cost
20,787 8,479 
Loans at FVOCI
3,490 338 
Loan commitments, financial guarantee contracts and
   customers’ liabilities under acceptances
(582)7,936 
Securities at amortized cost
(542)(157)
Securities at FVOCI
711 61 
Total23,745 16,717 


iii.Credit-impaired financial assets

Credit-impaired loans and advances are graded 8 to 10 in the Bank’s internal credit risk grading system.

The following table sets out a reconciliation of changes in the carrying amount of the allowance for credit losses for credit-impaired financial assets classified in stage 3:

Loans at amortized cost:September 30,
2026
December 31, 2025
Credit-impaired loans at beginning of period28,979 12,483 
Classified as credit-impaired during the period14,147 10,327 
Change in allowance for expected credit losses9,774 4,720 
Interest income427 828 
Write-offs(8,602)— 
Recoveries1,367 621 
Allowance for credit losses on credit-impaired loans at end of period46,092 28,979 











19

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

iv.Concentrations of credit risk

The Bank monitors concentrations of credit risk by sector, industry and country. An analysis of concentrations of credit risk from loans at amortized cost, loan commitments, financial guarantees and securities at amortized is as follows.

Concentration by sector and industry of instruments at amortized cost
Loans
 at amortized cost
Loan commitments,
financial guarantee contracts and acceptances outstanding
Securities
 at amortized cost
September 30,
2026
December 31, 2025September 30,
2026
December 31, 2025September 30,
2026
December 31, 2025
Gross amount11,509,557 9,158,236 318,933 161,597 1,441,921 1,360,497 
Amount committed/guaranteed— — 2,141,219 1,840,657 — — 
Concentration by sector
Corporations:
Private6,190,988 5,158,895 1,683,881 1,357,884 944,994 723,976 
State-owned1,321,253 1,194,949 89,700 254,122 42,791 45,516 
Financial institutions:
Private2,665,532 2,427,179 212,099 126,824 300,389 335,039 
State-owned362,014 257,479 474,472 263,424 49,339 65,038 
Sovereign969,770 119,734 — — 104,408 190,928 
Total11,509,557 9,158,236 2,460,152 2,002,254 1,441,921 1,360,497 
Concentration by industry
Financial institutions3,027,546 2,684,658 686,571 390,248 349,727 400,077 
Manufacturing2,513,152 2,864,918 547,767 448,860 530,166 403,603 
Oil and petroleum derived products2,099,074 1,264,187 542,021 707,990 106,892 98,876 
Agricultural436,900 330,621 26,820 28,950 — — 
Services956,221 686,726 415,336 251,670 164,293 152,037 
Mining383,193 387,599 50,290 60,914 47,463 20,014 
Sovereign969,770 119,734 — — 104,408 190,928 
Other1,123,701 819,793 191,347 113,622 138,972 94,962 
Total11,509,557 9,158,236 2,460,152 2,002,254 1,441,921 1,360,497 













20

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Concentration by sector and industry at FVOCI

Loans at FVOCISecurities FVOCI
September 30,
2026
December 31,
2025
September 30,
2026
December 31,
2025
Gross amount
898,653 77,240 379,613 69,476 
Concentration by sector
Corporations:
Private159,912 52,691 32,41532,415 — 
State-owned119,010 — 127,767 — 
Financial institutions:
Private119,585 19,424 1,994 — 
State-owned— 5,125 49,585 69,476 
Sovereign500,146 — 167,852 — 
Total898,653 77,240 379,613 69,476 
Concentration by industry
Financial institutions119,585 24,549 51,579 69,476 
Manufacturing119,123 — 44,586 — 
Oil and petroleum derived products82,379 — 70,194 — 
Agricultural15,571 15,627 — — 
Services24,844 — 37,512 — 
Mining37,005 37,064 — — 
Sovereign500,146 — 167,852 — 
Other— — 7,890 — 
Total898,653 77,240 379,613 69,476 
21

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Concentration by country risk financial instruments at amortized cost

Loans
 at amortized cost
Commitments,
financial guarantee contracts and acceptances outstanding
Securities
at amortized cost
September 30,
2026
December 31,
2025
September 30,
2026
December 31,
2025
September 30,
2026
December 31,
2025
Gross amount11,509,557 9,158,236 318,933 161,597 1,441,921 1,360,497 
Amount committed/guaranteed— — 2,141,219 1,840,657 — — 
Concentration by country
Argentina629,238 198,905 187,384 169,695 — — 
Australia— — — — 37,475 9,936 
Belgium— — — — 14,998 15,696 
Brazil1,276,928 1,130,060 136,442 135,428 — 7,009 
Canada— — 41,794 26,591 52,070 47,743 
Chile540,635 501,107 145,098 67,887 50,351 29,986 
China14,971 14,917 — — — — 
Colombia1,471,914 1,080,071 99,615 84,837 — 14,898 
Costa Rica417,448 461,965 82,791 61,212 — 8,141 
Dominican Republic901,670 919,673 221,409 135,214 — — 
Ecuador280,253 183,502 410,988 206,845 — — 
El Salvador229,213 100,756 8,254 29,084 — — 
Finland— — — — 19,723 13,365 
France107,527 68,555 3,895 72,443 14,719 15,011 
Germany— — 15,000 15,000 30,104 29,998 
Guatemala1,431,561 1,537,176 164,776 117,786 — — 
Honduras117,613 108,137 22,480 22,862 — — 
Ireland— — — — 24,566 14,408 
Italy15,048 23,375 14,976 1,442 — — 
Jamaica76,489 57,969 433 — — — 
Japan— — — — 71,087 60,402 
Korea— — — — 49,688 34,704 
Kuwait— — — — 20,365 20,159 
Mexico1,077,886 1,116,825 176,830 205,726 — 1,269 
Netherlands4,718 — 7,800 4,500 10,012 9,933 
Norway— — — — 37,649 24,577 
Panama1,794,063 571,207 118,616 35,989 4,968 75,494 
Paraguay193,197 210,047 250 250 — — 
Peru324,991 173,441 248,468 212,219 2,241 9,971 
Puerto Rico1,109 6,632 — 15,000 — — 
Qatar— — — — 29,954 30,103 
Saudi Arabia — — — — 48,429 49,919 
Singapore291,681 131,154 38,341 5,507 — — 
Trinidad and Tobago63,388 171,001 — 43,000 — — 
Sweden— — — — 6,332 14,932 
Suriname7,657 3,627 142,457 146,401 — — 
United States of America73,944 219,563 24,635 39,198 830,049 740,864 
United Kingdom138,119 103,665 147,100 141,696 49,785 50,315 
United Arab Emirates— — — — 9,983 3,521 
Uruguay28,296 64,906 320 6,442 — — 
Multilateral— — — — 27,373 28,143 
Total11,509,557 9,158,236 2,460,152 2,002,254 1,441,921 1,360,497 
22

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)

Risk rating and concentration by country financial instruments at FVOCI

Loans at FVOCISecurities at FVOCI
September 30,
2026
December 31,
2025
September 30,
2026
December 31,
2025
Gross amount
898,653 77,240 379,613 69,476 
Concentration by country
Argentina96,226 — — — 
Australia— — 36,024 — 
Chile— — 14,296 — 
Colombia119,010 — 32,415 — 
Costa Rica24,849 — 8,540 — 
Ecuador39,764 — — — 
El Salvador19,561 24,549 — — 
Guatemala41,493 15,627 1,994 — 
Korea— — 45,157 — 
Norway— — 34,414 — 
Panama515,139 — 47,060 — 
Dominican Republic37,005 37,064 58,332 — 
Singapore— — 3,631 — 
Trinidad and Tobago— — 48,165 — 
United Kingdom5,606 — — — 
Multilateral— — 49,585 69,476 
Total898,653 77,240 379,613 69,476 

v.Offsetting financial assets and liabilities

The following tables include financial assets and liabilities that are offset in the consolidated financial statement or subject to an enforceable master netting arrangement:

Derivative financial instruments – assets
September 30, 2026
Gross
amounts of
assets
Gross amounts
offset in the
consolidated
statement of
financial
position
Net amount of
assets presented
in the
consolidated
statement of
financial
position
Gross amounts not offset in
the consolidated statement of
financial position
Net
amount
Financial
instruments
Cash collateral
pledged
Derivative financial instruments used for hedging78,888 — 78,888 — (49,280)29,608 
Total78,888 — 78,888 — (49,280)29,608 

23

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

A. Credit risk (continued)
December 31, 2025
Gross
amounts of
assets
Gross amounts
offset in the
consolidated
statement of
financial
position
Net amount of
assets presented
in the
consolidated
statement of
financial
position
Gross amounts not offset in
the consolidated statement of
financial position
Net
amount
Financial
instruments
Cash collateral
pledged
Derivative financial instruments used for hedging69,837 — 69,837 — (49,266)20,571 
Total69,837 — 69,837 — (49,266)20,571 

Securities sold under repurchase agreements and derivative financial instruments – liabilities

September 30, 2026
Gross
amounts of
liabilities
Gross amounts
offset in the
consolidated
statement of
financial
position
Net amount of
liabilities presented
in the
consolidated
statement of
financial
position
Gross amounts
not offset in the consolidated
statement of
financial position
Net
amount
Financial
instruments
Cash collateral
pledged
Securities sold under repurchase agreements at amortized cost(248,514)— (248,514)255,965 3,096 10,547 
Derivative financial instruments used for hedging at FVTPL(73,623)— (73,623)— 19,000 (54,623)
Total(322,137)— (322,137)255,965 22,096 (44,076)

December 31, 2025
Gross
amounts of
liabilities
Gross amounts
offset in the
consolidated
statement of
financial
position
Net amount of
liabilities presented
in the
consolidated
statement of
financial
position
Gross amounts
not offset in the consolidated
statement of
financial position
Net
amount
Financial
instruments
Cash collateral
pledged
Securities sold under repurchase agreements at amortized cost(130,509)— (130,509)147,480 — 16,971 
Derivative financial instruments used for hedging at FVTPL(62,506)— (62,506)— 51,353 (11,153)
Total(193,015)— (193,015)147,480 51,353 5,818 
24

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)
    
B.Liquidity risk

i.Exposure to liquidity risk

The key measure used by the Bank for managing liquidity risk is the ratio of net liquid assets to deposits from customers and funding with a remaining tenor of 30 days. For this purpose, ‘net liquid assets’ include cash and cash equivalents which consist of deposits with bank, as well as corporate debt securities with investment grade.

The following table details the Bank's liquidity ratios:
September 30,
2026
December 31,
2025
At the end of the period147.80 %159.26 %
Period/year average115.83 %129.49 %
Maximum of the period161.52 %212.53 %
Minimum of the period101.56 %103.63 %
The following table includes the Bank’s liquid assets by country risk:
September 30, 2026December 31, 2025
(in millions of USD dollars)Cash and due from
banks
Securities FVOCITotalCash and due from
banks
Securities FVOCITotal
United States of America1,772 — 1,772 — 1,784 — 1,784 
Other O.E.C.D countries2 114 116 3 — 3 
Latin America6 14 20 5 — 5 
Other countries— 4 4 — — — 
Multilateral— 48 48 50 69 119 
Total1,780 180 1,960 1,842 69 1,911 
The following table includes the Bank’s demand deposits from customers and its ratio to total deposits from customers:
September 30,
2026
December 31,
2025
(in millions of USD dollars)
Demand and "overnight" deposits1,159 879 
Demand and "overnight" deposits to total deposits14.65 %13.31 %

The following table presents the total liquid assets available to meet the liquidity needs arising from customer deposits, their ratio to total customer deposits, and the amount of such assets maintained at the Federal Reserve Bank of the United States:

September 30,
2026
December 31,
2025
(in millions of USD dollars)
Total liquid assets1,960 1,911 
Total liquid assets to total customer deposits24.77 %28.94 %
Total liquid assets in the
  Federal Reserve of the United States of America
89.96 %90.74 %
25

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

B.Liquidity risk (continued)

Even though the average term of the Bank’s assets exceeds the average term of its liabilities, the associated liquidity risk is diminished by the short-term nature of a significant portion of the loan portfolio, since the Bank is primarily engaged in financing foreign trade.

The following table includes the outstanding principal balances for the Bank’s loans and securities short-term portfolio with maturity within one year based on their original contractual term along with its average remaining term:

(in millions of USD dollars)September 30,
2026
December 31,
2025
Loan and investment portfolio with original maturities of less than or equal 1 year7,415 5,247 
Average term (days)162 180 
The following table includes the carrying amount for the Bank’s loans and securities medium term portfolio with maturity over one year based on their original contractual terms along with their average remaining term:
(in millions of USD dollars)September 30,
2026
December 31,
2025
Loan and investment portfolio with original maturities of greater than 1 year6,709 5,349 
Average term (days)1,458 1,409 































26

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

B.Liquidity risk (continued)

ii.Maturity analysis for financial liabilities and financial assets

The following table details the future undiscounted cash flows of financial assets and liabilities grouped by their remaining maturity with respect to the contractual maturity:
September 30, 2026
Up to 3
months
3 to 6 months6 months to 1
year
1 to 5
years
More than 5
years
Gross inflows
(outflows)
Carrying
amount
Assets
Cash and due from banks1,830,853 11,247 — — — 1,842,100 1,841,669 
Securities112,036 149,053 288,673 1,416,127 22,214 1,988,103 1,821,093 
Loans4,126,065 1,761,220 2,856,919 4,413,019 399,874 13,557,097 12,321,300 
Customers' liabilities under acceptances259,065 44,076 15,792 — — 318,933 318,933 
Trading derivative assets— — 652 12,920 18,015 31,587 31,587 
Hedging derivative financial instruments - assets394 2,979 12,806 59,076 3,633 78,888 78,888 
Total6,328,413 1,968,575 3,174,842 5,901,142 443,736 17,816,708 16,413,470 
Liabilities
Customer deposits(6,463,061)(1,018,000)(267,946)(234,225)— (7,983,232)(7,964,564)
Securities sold under repurchase agreements(248,651)— — — — (248,651)(248,514)
Borrowings and debt(2,192,375)(855,383)(1,196,170)(2,101,671)(47,024)(6,392,623)(5,973,878)
Lease liabilities(579)(576)(1,153)(8,803)(11,938)(23,049)(18,962)
Acceptances outstanding(259,065)(44,076)(15,792)— — (318,933)(318,933)
Trading derivative liabilities— — (614)(11,514)(14,177)(26,305)(26,305)
Hedging derivative financial instruments - liabilities(8,942)(9,830)(5,590)(49,014)(247)(73,623)(73,623)
Total(9,172,673)(1,927,865)(1,487,265)(2,405,227)(73,386)(15,066,416)(14,624,779)
Subtotal net position(2,844,260)40,710 1,687,577 3,495,915 370,350 2,750,292 1,788,691 
Off-balance sheet contingencies
Documentary letters of credit186,219 145,735 1,894 — — 333,848 
Stand-by letters of credit and guarantees174,512 255,114 475,106 81,488 — 986,220 
Loans and letter of credit commitments82,393 66,310 198,492 440,385 33,571 821,151 
Total443,124 467,159 675,492 521,873 33,571 2,141,219 
Total net position(3,287,384)(426,449)1,012,085 2,974,042 336,779 609,073 






27

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

B.Liquidity risk (continued)            
December 31, 2025
Up to 3
months
3 to 6
months
6 months to 1
year
1 to 5
years
More than 5
years
Gross inflows
(outflows)
Carrying
amount
Assets
Cash and due from banks1,906,085 18,379 — — — 1,924,464 1,923,731 
Securities103,225 134,775 203,340 1,079,046 31,792 1,552,178 1,428,990 
Loans2,711,751 1,651,349 2,003,457 3,417,682 331,015 10,115,254 9,141,668 
Customers' liabilities under acceptances102,576 36,206 22,815 — — 161,597 161,597 
Trading derivative assets— — — — 1,569 1,569 1,569 
Hedging derivative financial instruments - assets7,989 189 3,685 54,654 3,320 69,837 69,837 
Total4,831,626 1,840,898 2,233,297 4,551,382 367,696 13,824,899 12,727,392 
Liabilities
Customer deposits(5,153,930)(745,511)(503,687)(263,845)— (6,666,973)(6,640,290)
Securities sold under repurchase agreements(7,800)(68,015)(58,631)— — (134,446)(130,509)
Borrowings and debt(1,093,223)(550,119)(447,676)(2,246,182)(49,796)(4,386,996)(4,030,389)
Lease liabilities(533)(531)(1,062)(8,134)(12,179)(22,439)(18,429)
Acceptances outstanding(102,576)(36,206)(22,815)— — (161,597)(161,597)
Trading derivative liabilities— — — — (433)(433)(433)
Hedging derivative financial instruments - liabilities(7,888)— (16,755)(37,459)(404)(62,506)(62,506)
Total(6,365,950)(1,400,382)(1,050,626)(2,555,620)(62,812)(11,435,390)(11,044,153)
Subtotal net position(1,534,324)440,516 1,182,671 1,995,762 304,884 2,389,509 1,683,239 
Off-balance sheet contingencies
Documentary letters of credit141,926 74,009 24,185 — — 240,120 
Stand-by letters of credit and guarantees301,972 169,182 255,763 109,517 — 836,434 
Loans and letter of credit commitments59,206 139,204 134,631 397,491 33,571 764,103 
Total503,104 382,395 414,579 507,008 33,571 1,840,657 
Total net position(2,037,428)58,121 768,092 1,488,754 271,313 548,852 






28

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

B.Liquidity risk (continued)
Future undiscounted cash flows presented in the table above on some financial assets and financial liabilities vary materially from contractual cash flows. The principal difference is that the undiscounted future cash flows of floating rate assets and liabilities are calculated using projected market rates.
The amounts in the tables above have been compiled as follows:

Type of financial instrumentBasis on which amounts are compiled
Financial assets and liabilitiesUndiscounted cash flows, which include estimated interest payments.
Issued financial guarantee contracts, and loan commitmentsEarliest possible contractual maturity. For issued financial guarantee contracts, the maximum amount of the guarantee is allocated to the earliest period in which the guarantee could be called.
Derivative financial assets and financial liabilities
Contractual undiscounted cash flows. The amounts shown are the gross nominal inflows and outflows for derivatives that simultaneously settle gross or net amounts.
iii.Liquidity reserves

As part of the management of liquidity risk arising from financial liabilities, the Bank holds liquid assets comprising cash and cash equivalents.

The following table sets out the components of the Banks’s liquidity reserves:
September 30, 2026December 31, 2025
AmountFair valueAmountFair value
Balances with Federal Reserve of the United
States of America
1,762,910 1,762,910 1,734,177 1,734,177 
Cash and balances with other bank (1)
16,874 16,874 108,031 108,031 
Total Liquidity reserves1,779,784 1,779,784 1,842,208 1,842,208 
(1)Excludes pledged deposits.


iv.Financial assets available to support future funding

The following table sets out the Bank’s financial assets available to support future funding:
September 30, 2026December 31, 2025
Pledged as collateralAvailable as collateralPledged as collateralAvailable as collateral
Cash and due from banks60,696 1,779,784 80,954 1,842,208 
Notional of investment securities1,452,801 375,384 510,029 929,898 
Loans at amortized cost - outstanding principal balance— 11,423,169 — 9,104,725 
Total1,513,497 13,578,337 590,983 11,876,831 
The total financial assets recognized in the consolidated statement of financial position that had been pledged as collateral for liabilities as of September 30, 2026 and December 31, 2025 are shown in the table above.

The Bank manages market risk by considering the consolidated financial situation of the Bank.     
29

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

C.Market risk

i.Interest rate risk
The table below details the Bank's exposure based on interest rate repricing/maturity date for the notional amount of the interest bearing financial assets and liabilities on interest-bearing financial assets and liabilities:
September 30, 2026
Up to 3
months
3 to 6
months
6 months to
1 year
1 to 5 yearsMore than 5
years
Non interest
rate risk
Total
Assets
Cash and due from banks1,826,565 11,000 — — — 2,915 1,840,480 
Securities - principal390,740 145,933 275,996 974,098 15,917 — 1,802,684 
Loans - principal balance7,797,287 3,637,404 593,316 233,178 60,277 — 12,321,462 
Total 10,014,592 3,794,337 869,312 1,207,276 76,194 2,915 15,964,626 
Liabilities
Customer deposits(6,443,182)(1,001,128)(259,310)(207,630)— (268)(7,911,518)
Securities sold under repurchase agreements(246,997)— — — — — (246,997)
Borrowings and debt(4,476,842)(959,082)(65,937)(438,502)— — (5,940,363)
Total(11,167,021)(1,960,210)(325,247)(646,132)— (268)(14,098,878)
Net effect of derivative financial instruments held
for interest risk management13,412 (20,177)61 17,251 — — 10,547 
Total interest rate sensitivity(1,139,017)1,813,950 544,126 578,395 76,194 2,647 1,876,295 
December 31, 2025
Up to 3
months
3 to 6
months
6 months to
1 year
1 to 5 yearsMore than 5
years
Non interest
rate risk
Total
Assets
Cash and due from banks1,890,450 18,000 — — — 14,712 1,923,162 
Securities - principal268,495 132,025 195,048 797,495 21,571 — 1,414,634 
Loans - principal balance5,441,055 2,170,978 1,263,048 301,109 5,111 — 9,181,301 
Total7,600,000 2,321,003 1,458,096 1,098,604 26,682 14,712 12,519,097 
Liabilities
Customer deposits(5,136,030)(792,898)(426,691)(244,735)— (3,862)(6,604,216)
Securities sold under repurchase agreements(129,698)— — — — — (129,698)
Borrowings and debt(2,794,546)(674,844)(106,834)(416,874)— — (3,993,098)
Total(8,060,274)(1,467,742)(533,525)(661,609)— (3,862)(10,727,012)
Net effect of derivative financial instruments held
for interest risk management5,138 371 (1,041)4,043 — — 8,511 
Total interest rate sensitivity(455,136)853,632 923,530 441,038 26,682 10,850 1,800,596 


30

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)
C.Market risk (continued)

Interest rate risk management is complemented by monitoring the sensitivity of the Bank´s financial assets and liabilities, considering several standard interest rate scenarios. The standard scenarios considered monthly include a parallel decline or increase of 50bps, 100bps, and 200 bps across all yield curves, which are evaluated based on market behavior.

The Bank performs a sensitivity analysis of the most likely increase or decrease in market interest rates at the reporting date, assuming non-asymmetric movements in the yield curves and a constant financial situation to assess the effect on profit or loss.

Interest rate sensitivity analysis affect reported equity in the following ways:
-    Retained earnings: increases or decreases in net interest income and in fair values of derivatives reported in profit or loss;
-    Fair value reserve: increases or decreases in fair values of financial assets at FVOCI reported directly in equity; and
-    Hedging reserve: increases or decreases in fair values of hedging instruments designated in qualifying cash flow hedge relationships.
This sensitivity provides an analysis of changes in interest rates, considering the previous year´s interest rate volatility.

Additionally, the Bank measures the sensitivity of the equity value (EVE) following the methodology described by the Basel Committee on Banking Supervision, which measures the interest rate risk embedded in the equity value, which for interest rate risk purposes is defined as the difference between the net present value of assets less the net present value of liabilities due, based on the impact of a change in interest rates on such present values.

The following table presents the sensitivity analysis performed for the Bank:
    
Change in
interest rate
Effect on
profit or loss
Effect on
equity
Effect on equity value (EVE)
September 30, 2026+50 bps(1,214)153 (13,733)
-50 bps1,607 (193)13,891 
December 31, 2025+50 bps1,592 5,215 (9,823)
-50 bps(1,773)(5,320)9,911 
31

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
3.Financial risk review (continued)

C.Market risk (continued)

ii.     Foreign exchange risk
The following table presents the maximum exposure amount in foreign currency of the Bank’s carrying amount of total assets and liabilities, except for hedging relationships.
September 30, 2026
Brazilian
Real
European
Euro
Japanese
Yen
Colombian
Peso
Mexican
Peso
Other
Currencies(1)
Total
Exchange rate
5.17 1.13 157.31 3,311.26 18.06 
Assets
Cash and due from banks154 232 8 56 969 229 1,648 
Loans— 33,315 — — 434,268 27,492 495,075 
Total154 33,547 8 56 435,237 27,721 496,723 
Liabilities
Borrowings and debt— (33,315)— — (435,636)(27,492)(496,443)
Total— (33,315)— — (435,636)(27,492)(496,443)
Net currency position154 232 8 56 (399)229 280 
    

December 31, 2025
Brazilian
Real
European EuroJapanese
Yen
Colombian
Peso
Mexican
Peso
Other
Currencies(1)
Total
Exchange rate
5.49 1.17 156.74 3,773.58 18.01 
Assets
Cash and due from banks60 1,847 8 50 2,309 80 4,354 
Loans— 27,472 — — 415,704 25,175 468,351 
Total60 29,319 8 50 418,013 25,255 472,705 
Liabilities
Borrowings and debt— (28,910)— — (417,953)(25,175)(472,038)
Total— (28,910)— — (417,953)(25,175)(472,038)
Net currency position60 409 8 50 60 80 667 
(1)It includes other currencies such as: Argentine pesos, Australian dollar, Swiss franc, Sterling pound, Costa Rican colones and Peruvian soles.
.


32

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
4.Fair value of financial instruments

A.Recurring fair value measurements

Financial instruments measured at fair value on a recurring basis by caption on the consolidated statement of financial position using the fair value hierarchy are described below:
September 30, 2026
Level 1Level 2Level 3Total
Assets
Loans at FVOCI— 898,653 — 898,653 
Securities at FVOCI
Corporations:
Private— 32,415 — 32,415 
State-owned— 127,767 — 127,767 
Financial institutions:
Private— 1,994 — 1,994 
State-owned— 49,585 — 49,585 
Sovereign— 167,852 — 167,852 
Total loans and securities at FVOCI— 1,278,266 — 1,278,266 
Derivative financial instruments - assets:
  For trading:
    Interest rate swaps— 30,934 — 30,934 
    Foreign exchange forwards
— 653 — 653 
  For hedging:
    Interest rate swaps— 11,900 — 11,900 
    Cross-currency swaps— 66,927 — 66,927 
    Foreign exchange forwards— 61 — 61 
Total derivative financial instrument assets— 110,475 — 110,475 
Total assets at fair value— 1,388,741 — 1,388,741 
Liabilities
Derivative financial instruments - liabilities:
  For trading:
    Interest rate swaps— (25,690)— (25,690)
    Foreign exchange forwards— (615)— (615)
  For hedging:
    Interest rate swaps— (14,225)— (14,225)
    Cross-currency swaps— (59,398)— (59,398)
Total derivative financial instruments - liabilities— (99,928)— (99,928)
Total liabilities at fair value— (99,928)— (99,928)







33

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
4.Fair value of financial instruments (continued)

A.Recurring fair value measurements (continued)

December 31, 2025
Level 1Level 2Level 3Total
Assets
Loans at FVOCI— 77,240 — 77,240 
Financial institutions:
State-owned— 69,476 — 69,476 
Total securities and other financial assets— 146,716 — 146,716 
Derivative financial instruments - assets:
  For trading:
    Interest rate swaps— 1,569 — 1,569 
  For hedging:
    Interest rate swaps— 26,075 — 26,075 
    Cross-currency swaps— 43,762 — 43,762 
Total derivative financial instrument assets— 71,406 — 71,406 
Total assets at fair value— 218,122 — 218,122 
Liabilities
Derivative financial instruments - liabilities:
  For trading:
    Interest rate swaps— (433)— (433)
  For hedging:
    Interest rate swaps— (5,435)— (5,435)
    Cross-currency swaps— (57,027)— (57,027)
Foreign exchange forwards— (44)— (44)
Total derivative financial instruments - liabilities— (62,939)— (62,939)
Total liabilities at fair value— (62,939)— (62,939)
34

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
4.Fair value of financial instruments (continued)

B.Non-recurring fair value measurements

The following table provides information on the carrying value and the estimated fair value of the Bank’s financial instruments not measured at fair value:
September 30, 2026
Carrying
value
Fair
value
Level 1Level 2Level 3
Assets
Cash and deposits in banks1,841,669 1,841,669 — 1,841,669 — 
Securities at amortized cost (1)
1,441,480 1,433,286 — 1,433,286 — 
Loans at amortized cost (2)
11,422,647 11,735,526 — 11,735,526 — 
Customers' liabilities under acceptances318,933 318,933 — 318,933 — 
Liabilities
Customer deposits7,964,564 7,964,564 — 7,964,564 — 
Securities sold under repurchase agreements248,514 248,514 — 248,514 — 
Borrowings and debt5,973,878 6,006,887 — 6,006,887 — 
Acceptances outstanding318,933 318,933 — 318,933 — 
December 31, 2025
Carrying
value
Fair
value
Level 1Level 2Level 3
Assets
Cash and deposits in banks1,923,731 1,923,731 — 1,923,731 — 
Securities at amortized cost (1)
1,359,514 1,375,788 — 1,375,788 — 
Loans at amortized cost (2)
9,064,428 9,319,038 — 9,319,038 — 
Customers' liabilities under acceptances161,597 161,597 — 161,597 — 
Liabilities
Customer deposits6,640,290 6,640,290 — 6,640,290 — 
Securities sold under repurchase agreements130,509 130,509 — 130,509 — 
Borrowings and debt4,030,389 4,071,789 — 4,071,789 — 
Acceptances outstanding161,597 161,597 — 161,597 — 
(1)The carrying value of securities at amortized cost includes accrued interest receivable of $13.3 million and is presented net of the allowance for expected credit losses of $441.3 thousand as of September 30, 2026 (accrued interest receivable of $14.8 million and the allowance for expected credit losses of $1 million as of December 31, 2025).
(2)The carrying value of loans at amortized cost includes accrued interest receivable of $121.3 million and is presented net of the allowance for expected credit losses of $86.9 million and unearned interest and deferred fees of $34.9 million as of September 30, 2026 (accrued interest receivable of $87.8 million, the allowance for expected credit losses of $93.8 million and unearned interest and deferred fees of $34.3 million as of December 31, 2025).





35

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
5.Cash and due from banks

The following table presents the details of interest-bearing deposits in banks and restricted deposits:
September 30,
2026
December 31,
2025
Demand deposits (1)
1,779,784 1,767,208 
Time deposits — 75,000 
Total cash and due from banks1,779,784 1,842,208 
Time deposits with original maturity over 90 days and other restricted and pledged deposits (2)
60,696 80,954 
Total cash and due from banks1,840,480 1,923,162 
Interest receivable deposits1,225 724 
Total cash and due from banks and interest1,841,705 1,923,886 
Less: Allowance for credit losses(36)(155)
Total cash and due from banks, net1,841,669 1,923,731 

The following table presents the pledged and restricted deposits classified by country risk:
September 30,
2026
December 31,
2025
Country:
Chile(2)
37,000 28,000 
Germany— 12,114 
Japan140 15,860 
Panama1,600 1,600 
Spain1,363 — 
United Kingdom1,733 — 
United States of America18,860 23,380 
Total60,696 80,954 

(1) Demand deposits includes $1,763 million (December 31, 2025: $1,734 million) at Federal Reserve of United States of America.
(2) As a September 30, 2026 restricted deposit of $37 million are included (December 31, 2025: $28 million), with the New York State Department of Financial Services under March 1994 legislation.

The following table shows cash and deposits in local and foreign banks, based on the ratings assigned by the rating agencies:

September 30,
2026
December 31,
2025
Credit rating:
Aaa-Aa31,767,011 1,739,387 
A1-A366,575 94,735 
Baa1-Baa35,762 77,952 
Ba1-Ba3451 200 
Caa1-Caa366 75 
No rating
615 10,813 
1,840,480 1,923,162 



36

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
6.Investment securities

Securities are presented as follows:
September 30, 2026Amortized cost
FVOCI (1)
Total
Principal1,428,574 374,110 1,802,684 
Interest receivable13,347 5,503 18,850 
Gross amount1,441,921 379,613 1,821,534 
Allowance (1)
(441)— (441)
Total1,441,480 379,613 1,821,093 

December 31, 2025Amortized cost
FVOCI (1)
Total
Principal1,345,742 68,892 1,414,634 
Interest receivable14,755 584 15,339 
Gross amount1,360,497 69,476 1,429,973 
Allowance (1)
(983)— (983)
Total1,359,514 69,476 1,428,990 

(1)As of September 30, 2026 and December 31, 2025, the allowance for credit losses on securities at FVOCI for $727 thousand and $16 thousand, respectively, is included in the equity within Other comprehensive income in the consolidated statement of financial position.

Securities by contractual maturity are shown in the following table:
September 30, 2026Amortized costFVOCITotal
Due within 1 year436,285 101,800 538,085 
After 1 to 5 years992,289 256,393 1,248,682 
After 5 to 10 years— 15,917 15,917 
Balance - principal1,428,574 374,110 1,802,684 
December 31, 2025Amortized costFVOCITotal
Due within 1 year372,910 55,540 428,450 
After 1 to 5 years951,261 13,352 964,613 
After 5 to 10 years21,571 — 21,571 
Balance - principal1,345,742 68,892 1,414,634 

The following table includes the securities pledged to secure repurchase transactions (see note 12):
September 30,
2026
December 31,
2025
Securities pledged to secure repurchase transactions255,965 147,480 
Securities sold under repurchase agreements(248,514)(130,509)
As of September 30, 2026, investments measured at amortized cost totaling $30 million that had experienced a significant increase in credit risk were sold.

37

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
7.Loans

The following table presents the loan portfolio according to its classification and subsequent measurement:

September 30, 2026Amortized cost
FVOCI (1)
Total
Loans - principal balance11,423,169 898,293 12,321,462 
Interest receivable121,253 4,106 125,359 
Unearned interest and deferred fees(34,865)(3,746)(38,611)
Gross balance11,509,557 898,653 12,408,210 
Allowance for credit losses(86,910)— (86,910)
Loans, net11,422,647 898,653 12,321,300 
December 31, 2025Amortized cost
FVOCI (1)
Total
Loans - principal balance9,104,725 76,576 9,181,301 
Interest receivable87,837 982 88,819 
Unearned interest and deferred fees(34,326)(318)(34,644)
Gross balance9,158,236 77,240 9,235,476 
Allowance for credit losses(93,808)— (93,808)
Loans, net9,064,428 77,240 9,141,668 
(1)As of September 30, 2026, the allowance for credit losses of loans at FVOCI for $3,9 million (December 31,2025: $468 thousand) are included in the equity in the consolidated statement of financial position in the line Other comprehensive income.
As of September 30, 2026, the Bank sold loans measured at FVTPL for $7 million, realizing gain of $26 thousand, loans measured at FVOCI for $10 million, realizing gain of $75 thousand, and amortized cost measured loans for $90 million, of which $60 million are for credit risk.
The fixed and floating interest rate distribution of the loan portfolio is as follows:
September 30,
2026
December 31,
2025
Fixed interest rate6,066,352 5,065,160 
Floating interest rates6,341,858 4,170,316 
Total12,408,210 9,235,476 
As of September 30, 2026, 81% (December 31, 2025: 70%) of the loan portfolio at fixed interest rates has remaining maturities of less than 180 days. Interest rates on loans ranges from 2.39% to 16.28% (December 31, 2025: 3.70% to 16.28%).








38

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
8.Loan commitments and financial guarantee contracts

The Bank’s outstanding loan commitments and financial guarantee contracts are as follows:
September 30,
2026
December 31,
2025
Documentary letters of credit333,848 240,120 
Stand-by letters of credit and guarantees - commercial risk986,220 836,434 
Loans Commitments723,758 720,435 
Letters of credit Commitments 97,393 43,668 
Total2,141,219 1,840,657 

The remaining maturity profile of the Bank’s outstanding loan commitments and financial guarantee contracts is as follows:
September 30,
2026
December 31,
2025
Up to 1 year1,596,015 1,331,002 
From 1 to 2 years138,664 213,223 
Over 2 to 5 years372,969 262,861 
More than 5 years33,571 33,571 
Total2,141,219 1,840,657 

9. Derivative financial instruments

A.Trading derivative financial instruments

The following table details quantitative information on the notional amount and carrying amount of trading derivative instruments:
September 30, 2026December 31, 2025
Notional
amount
Carrying amount of trading derivative
Notional
amount
Carrying amount of trading derivative
AssetLiability AssetLiability
Interest Rate Swap1,233,943 30,934 (25,690)536,716 1,569 (433)
Forward contract26,213 653 (615)— — — 
1,260,156 31,587 (26,305)536,716 1,569 (433)

September 30, 2026December 31, 2025
Forward contractInterest rate swapTotalForward contractInterest rate swapTotal
Up to 1 year
26,213 — 26,213 — — — 
Over 2 to 5 years— 817,717 817,717 — 286,716 286,716 
More than 5 years— 416,226 416,226 — 250,000 250,000 
Total26,213 1,233,943 1,260,156 — 536,716 536,716 



39

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments

The following table details quantitative information on the notional amounts and carrying amounts of the derivative instruments used for hedging by type of risk hedged and type of hedge:
September 30, 2026December 31, 2025
Notional
amount (2)
Carrying amount of hedging instruments
Notional
amount (2)
Carrying amount of hedging instruments
Asset (1)
Liability (1)
Asset (1)
Liability (1)
Interest rate risk
  Fair value hedges1,647,151 11,900 (14,225)1,217,765 26,075 (5,435)
Interest rate and foreign exchange risk
  Fair value hedges485,073 32,605 (9,689)204,032 13,012 (9,730)
  Cash flow hedges1,668,387 34,322 (49,709)1,113,263 30,750 (47,297)
Foreign exchange risk
  Cash flow hedges6,032 61 — 7,039 — (44)
3,806,643 78,888 (73,623)2,542,099 69,837 (62,506)
(1)Included in the consolidated statement of financial position under the line Hedging derivative financial instruments - assets or liabilities.
(2)At September 30, 2026 the notional amounts of derivative financial instruments include $2,036 million (December 31, 2025: $1,234.5 million) of interest rate swaps and cross currency interest rate swaps, which were designated in aggregate exposure hedges hedging underlying assets totaling $1,973 million (December 31, 2025: $1,217.4 million at).


























40

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)

Fair value hedges

The following table details the notional amounts and carrying amounts of derivative instruments used in fair value hedges by type of risk and hedged item, along with the changes during the years used to determine and recognize the ineffectiveness of the hedge:
September 30, 2026
Notional amount
Carrying amount of
hedging instruments
Changes in fair
value used to
calculate hedge
ineffectiveness (2)
Ineffectiveness
recognized in
profit or loss (2)
Asset (1)
Liability (1)
Interest rate risk
  Loans25,000 524 — 1,167 72 
  Securities at amortized cost285,261 2,738 (176)7,369 (1,188)
  Customer deposits60,000 64 — (237)44 
  Borrowings and debt1,276,890 8,575 (14,049)(26,760)96 
Interest rate and foreign exchange risk
  Loans292,979 22,177 (554)21,342 561 
  Borrowings and debt192,094 10,427 (9,135)(950)631 
Total2,132,224 44,505 (23,914)1,931 216 
December 31, 2025
Notional amount
Carrying amount of
hedging instruments
Changes in fair
value used to
calculate hedge
ineffectiveness (2)
Ineffectiveness
recognized in
profit or loss (2)
Asset (1)
Liability (1)
Interest rate risk
  Loans25,000 — (644)(636)(29)
  Securities at amortized cost164,600 — (4,383)(2,932)655 
  Customer deposits60,000 270 — 384 (7)
  Repurchase agreements60,485 147 (395)9 (65)
  Borrowings and debt907,680 25,658 (13)14,279 263 
Interest rate and foreign exchange risk
  Loans11,938 — (742)(648)74 
  Borrowings and debt192,094 13,012 (8,988)16,553 (431)
Total1,421,797 39,087 (15,165)27,009 460 

(1)Included in the consolidated statement of financial position under the line Hedging derivative financial instruments - assets or liabilities.
(2)Included in the consolidated statement of profit or loss under the line Gain on financial instruments, net.
41

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)

The following table details the notional amounts and carrying amounts of the fair value hedged items by type of risk and hedged item, along with the changes during the period used to determine and recognize the ineffectiveness of the hedge:

September 30, 2026
Carrying amount of
hedged items
Line in the consolidated
statement of financial
position that includes the
carrying amount of the
hedged items
Accumulated amount of
fair value hedge
adjustments included in
the carrying amount of the
hedged items
Change in fair value of
the hedged items used
to calculate hedge
ineffectiveness (1)
AssetLiability
Interest rate risk
  Loans24,843 — Loans(488)(1,095)
  Securities at amortized cost283,962 — Securities(5,473)(8,557)
  Customer deposits— (61,003)Customer deposits9 281 
  Borrowings and debt— (262,223)Borrowings and debt17,568 26,856 
Interest rate and foreign exchange risk
  Loans291,401 — Loans(20,059)(20,781)
  Borrowings and debt— (193,480)Borrowings and debt(1,075)1,581 
Total600,206 (516,706)(9,518)(1,715)
December 31, 2025
Carrying amount of
hedged items
Line in the consolidated
statement of financial
position that includes the
carrying amount of the
hedged items
Accumulated amount of
fair value hedge
adjustments included in
the carrying amount of the
hedged items
Change in fair value of
the hedged items used
to calculate hedge
ineffectiveness (1)
AssetLiability
Interest rate risk
  Loans25,938 — Loans607 607 
  Securities at amortized cost169,643 — Securities3,587 3,587 
  Customer deposits— (60,477)Customer deposits(273)(391)
  Repurchase agreements— (61,027)Securities sold under repurchase agreements(168)(74)
  Borrowings and debt— (301,065)Borrowings and debt(10,171)(14,016)
Interest rate and foreign exchange risk
  Loans12,117 — Loans722 722 
  Borrowings and debt— (196,801)Borrowings and debt(2,669)(16,984)
Total207,698 (619,370)(8,365)(26,549)

(1)Included in the consolidated statement of profit or loss under the line Gain on financial instruments, net.



42

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)

The following table details the maturity of the notional amount for the derivative instruments used in fair value hedges:

September 30, 2026December 31, 2025
Interest
rate
swaps
Cross currency swapsTotalInterest
rate
swaps
Cross currency swapsTotal
Up to 1 year
411,652 142,059 553,711 374,769 19,882 394,651 
From 1 to 2 years
372,141 283,696 655,837 298,293 122,176 420,469 
Over 2 to 5 years834,090 49,193 883,283 515,435 51,849 567,284 
More than 5 years29,268 10,125 39,393 29,268 10,125 39,393 
Total1,647,151 485,073 2,132,224 1,217,765 204,032 1,421,797 

The following table details the ineffectiveness recognized in profit or loss for the derivative instruments used in fair value hedges:

Three months ended September 30, 2026Nine months ended September 30, 2026
OutstandingMaturedTotalOutstandingMaturedTotal
Ineffectiveness recognized in profit or loss
Interest rate risk
  Loans71 — 71 72 — 72 
  Securities at amortized cost133 — 133 (1,188)(334)(1,522)
  Customer deposits(1)— (1)44 — 44 
  Repurchase agreements(47)50 3 — 55 55 
  Borrowings and debt(401)15 (386)96 17 113 
Interest rate and foreign exchange risk
  Loans190 — 190 561 — 561 
  Borrowings and debt182 — 182 631 — 631 
Total127 65 192 216 (262)(46)
Three months ended September 30, 2025Nine months ended September 30, 2025
OutstandingMaturedTotalOutstandingMaturedTotal
Ineffectiveness recognized in profit or loss
Interest rate risk
  Loans3 — 3 (46)— (46)
  Securities at amortized cost75 — 75 502 — 502 
  Customer deposits(7)— (7)(4)— (4)
  Repurchase agreements(57)— (57)(62)(28)(90)
  Borrowings and debt8 — 8 401 144 545 
Interest rate and foreign exchange risk
  Loans(152)— (152)92 — 92 
  Borrowings and debt(509)— (509)(430)— (430)
Total(639)— (639)453 116 569 
43

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)

Cash flow hedges

The following table details the notional amounts and carrying amounts of derivative instruments used in cash flow hedges by type of risk and hedged item, along with the changes during the period used to determine and recognize the ineffectiveness of the hedge:
September 30, 2026
Carrying amount of
hedging instruments
Change in fair
value used for
calculating
hedge
ineffectiveness
Changes in the
fair value of the
hedging
instruments
recognized in
OCI (2)
Ineffectiveness
recognized in
profit or loss (3)
Amount
reclassified
from the hedge
reserve to profit
or loss (4)
Nominal
amount
Asset (1)
Liability (1)
Interest rate and foreign exchange risk
  Loans9,345 151 — 810 810 — — 
  Borrowings and debt1,659,042 34,171 (49,709)(9,381)(9,328)53 92 
Foreign exchange risk
  Loans6,032 61 — 61 61 — 2 
  Borrowings and debt— — — — — — (52)
Total1,674,419 34,383 (49,709)(8,510)(8,457)53 42 

December 31, 2025
Carrying amount of
hedging instruments
Change in fair
value used for
calculating
hedge
ineffectiveness
Changes in the
fair value of the
hedging
instruments
recognized in
OCI (2)
Ineffectiveness
recognized in
profit or loss (3)
Amount
reclassified
from the hedge
reserve to profit
or loss (4)
Nominal
amount
Asset (1)
Liability (1)
Interest rate and foreign exchange risk
  Loans20,658 — (1,697)(1,810)(1,810)— (44)
  Borrowings and debt1,092,605 30,750 (45,600)100,248 100,802 554 (466)
Foreign exchange risk
  Loans7,039 — (44)(44)(44)— (278)
  Deposits— — — — — — 3 
  Borrowings and debt— — — — — — 22 
Total1,120,302 30,750 (47,341)98,394 98,948 554 (763)


(1) Included in the consolidated statement of financial position under the line Hedging derivative financial instruments - assets or liabilities.
(2) Included in equity in the consolidated statement of financial position under the line Other comprehensive income (loss).
(3) Hedge ineffectiveness attributable to outstanding hedges included in the consolidated statement of profit or loss in the line Gain on financial instruments, net.
(4) Hedging reserve attributable to expired hedges reclassified to the consolidated statement of profit or loss in the line Gain on financial instruments, net.


44

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)
The following table details the carrying amounts of the cash flow hedged items by type of risk and hedged item, along with the changes during the period used to determine and recognize the ineffectiveness of the hedge:
September 30, 2026
Carrying amount of
hedged items
Line in the consolidated
statement of financial
position that includes
the carrying amount of
the hedged items
Change in the fair value
of the hedged items used
to calculate the hedge
ineffectiveness (1)
Cash flow
hedge reserve
AssetLiability
Interest rate risk
  Borrowings and debt— — Borrowings and debt— (17,841)
Interest rate and foreign exchange risk
  Loans9,991 — Loans(810)— 
  Borrowings and debt— (700,366)Borrowings and debt9,381 27,473 
Foreign exchange risk
  Loans5,725 — Loans(61)13 
Total15,716 (700,366)8,510 9,645 
December 31, 2025
Carrying amount of
hedged items
Line in the consolidated
statement of financial
position that includes
the carrying amount of
the hedged items
Change in the fair value
of the hedged items used
to calculate the hedge
ineffectiveness (1)
Cash flow
hedge reserve
AssetLiability
Interest rate and foreign exchange risk
  Loans21,191 — Loans1,810 (61)
  Borrowings and debt— (1,101,787)Borrowings and debt(100,248)1,332 
Foreign exchange risk
  Loans7,077 — Loans44 29 
Total28,268 (1,101,787)(98,394)1,300 

The following table details the maturity of the derivative instruments used in cash flow hedges:

September 30, 2026December 31, 2025
Foreign exchange forward contractCross currency swapsTotalForeign exchange forward contractCross currency swapsTotal
Up to 1 year
6,032 423,140 429,172 7,039 324,098 331,137 
From 1 to 2 years
— 490,663 490,663 — 116,762 116,762 
Over 2 to 5 years— 725,316 725,316 — 643,135 643,135 
More than 5 years— 29,268 29,268 — 29,268 29,268 
Total6,032 1,668,387 1,674,419 7,039 1,113,263 1,120,302 





45

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
9.Derivative financial instruments (continued)

B. Hedging derivative financial instruments (continued)

The following table details the ineffectiveness recognized in profit or loss for the derivative instruments used in cash flow hedges:    

Three months ended September 30, 2026Nine months ended September 30, 2026
OutstandingMaturedTotalOutstandingMaturedTotal
Ineffectiveness recognized in profit or loss
Interest rate and foreign exchange risk
  Borrowings and debt(119)91 (28)53 92 145 
Foreign exchange risk
  Loans— — — — 2 2 
  Borrowings and debt(4)(52)(56)— (52)(52)
Total(123)39 (84)53 42 95 
Three months ended September 30, 2025Nine months ended September 30, 2025
OutstandingMaturedTotalOutstandingMaturedTotal
Ineffectiveness recognized in profit or loss
Interest rate and foreign exchange risk
  Loans— 1 1 — (44)(44)
  Borrowings and debt(177)(638)(815)698 (468)230 
Foreign exchange risk
Loans— (286)(286)— (286)(286)
  Deposits— 44 44 — 3 3 
Borrowings and debt(1)— (1)(1)— (1)
Total(178)(879)(1,057)697 (795)(98)
10.Other assets

Following is a summary of other assets:
September 30,
2026
December 31,
2025
Other accounts receivable9,040 5,480 
Prepaid expenses4,124 1,173 
Prepaid fees and commissions604 567 
Technology projects under development13,142 9,755 
Improvement project under development1,518 1,710 
Severance fund3,317 2,934 
Other4,590 6,965 
Total36,335 28,584 



46

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
11. Customer deposits

Following is a summary of customer deposits:

September 30,
2026
December 31,
2025
Demand deposits573,359 698,570 
Time deposits7,338,159 5,905,646 
7,911,518 6,604,216 
Interest payable53,046 36,074 
Total7,964,564 6,640,290 

The remaining and contractual maturity profile of the Bank's deposits, excluding interest payable, is as follows:

Remaining termOriginal contractual
September 30,
2026
December 31,
2025
September 30,
2026
December 31,
2025
Demand573,359 698,570 573,359 698,570 
Up to 1 month3,906,807 3,110,156 2,684,440 2,033,327 
From 1 to 3 months
1,963,283 1,331,165 1,320,298 1,291,076 
From 3 to 6 months
1,001,128 732,639 1,767,586 1,420,130 
From 6 month to 1 year259,310 487,901 1,050,931 824,770 
From 1 to 2 years
84,233 217,045 384,318 303,104 
From 2 to 5 years
123,398 26,740 130,586 33,239 
Total7,911,518 6,604,216 7,911,518 6,604,216 
The following table presents additional information regarding the Bank’s deposits:
September 30,
2026
December 31,
2025
Aggregate amount of $100,000 or more7,910,890 6,603,585 
Aggregate amount of deposits in the New York Agency2,607,516 1,891,001 

Three months ended September 30,Nine months ended September 30,
2026202520262025
Interest expense on deposits made in the New York Agency28,980 19,665 71,504 56,386 












47

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
12.Securities sold under repurchase agreements
The following table details the financing under repurchase agreement:
September 30,
2026
December 31,
2025
Financing transactions under repurchase agreements246,997 129,698 
Interest payable
1,517 811 
Total financing under repurchase agreement248,514 130,509 
Three months ended September 30,Nine months ended September 30,
2026202520262025
Interest expense on financing contracts under repurchase agreement2,082 1,752 5,922 7,013 

Financing contracts under repurchase agreements bear interest at rates ranging from 4.15% to 4.50% with maturities up to December 7, 2026 (December 31, 2025: from 4.20% to 5.36%, with maturities up to October 16, 2026).
As indicated in Note 6, as of September 30, 2026, the repurchase agreements were secured by investments classified as amortized cost by the amount of $256 million (December 31, 2025: $147 million).
13. Borrowings and debt

Some borrowing agreements include various events of default and covenants relating to minimum capital adequacy ratios, incurrence of additional liens, and asset sales, as well as other customary covenants, representations and warranties. As of September 30, 2026, the Bank was in compliance with all those covenants.

Carrying amount of borrowings and debt is detailed as follows:
September 30, 2026
Short-TermLong-term
BorrowingsDebtBorrowingsDebtTotal
Principal3,152,975 750 777,988 2,016,507 5,948,220 
Transaction costs(85)(1)(2,058)(5,713)(7,857)
Interest payable13,890 4 1,815 17,806 33,515 
3,166,780 753 777,745 2,028,600 5,973,878 
December 31, 2025
Short-TermLong-term
BorrowingsDebtBorrowingsDebtTotal
Principal1,508,959 1,750 757,775 1,732,286 4,000,770 
Transaction costs(48)(2)(2,952)(4,670)(7,672)
Interest payable9,095 5 7,787 20,404 37,291 
1,518,006 1,753 762,610 1,748,020 4,030,389 
48

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
13.Borrowings and debt (continued)

Short-term borrowings and debt

The breakdown of short-term (original maturity of less than one year) borrowings and debt, along with contractual interest rates, is as follows:
September 30,
2026
December 31,
2025
Short-term borrowings:
At fixed interest rates2,769,273 1,508,959 
At floating interest rates383,702 — 
Principal3,152,975 1,508,959 
Less: Transaction costs(85)(48)
Interest payable13,890 9,095 
Total short-term borrowings, net3,166,780 1,518,006 
Short-term debt:
At fixed interest rates750 1,750 
Principal750 1,750 
Less: Transaction costs(1)(2)
Interest payable4 5 
Total short-term debt, net753 1,753 
Total short-term borrowings and debt3,167,533 1,519,759 
Range of fixed interest rates on borrowings and debt in U.S. dollars4.00% to 5.15%3.75% to 4.77%
Range of floating interest rates on borrowings in U.S. dollars4.06% to 4.67%— 
Range of fixed interest rates on borrowings in Mexican pesos6.85% to 7.6%7.68% to 7.72%
Range of floating interest rates on borrowings and debt in Mexican pesos7.20 %— 
Range of fixed interest rates on borrowings and debt in Euros
2.94% to 3.67%
2.52% to 2.63%
    

The outstanding balances of short-term borrowings and debt by currency, excluding prepaid transaction costs, are as follows:

September 30,
2026
December 31,
2025
US dollar2,797,257 1,455,149 
Mexican peso323,153 26,650 
Euros33,315 28,910 
Total3,153,725 1,510,709 
    
49

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
13.Borrowings and debt (continued)

Long-term borrowings and debt

The breakdown of long-term borrowings and debt (original maturity of more than one year), along with contractual interest rates, plus transaction costs are as follows:

September 30,
2026
December 31,
2025
Long-term borrowings:
At fixed interest rates52,709 64,244 
At floating interest rates725,279 693,531 
Principal777,988 757,775 
Less: Transaction costs(2,058)(2,952)
Interest payable1,815 7,787 
Total long-term borrowings, net777,745 762,610 
Long-term debt:
At fixed interest rates722,072 737,148 
At floating interest rates1,294,435 995,138 
Principal2,016,507 1,732,286 
Less:Transaction costs(5,713)(4,670)
Interest payable17,806 20,404 
Total long-term debt, net2,028,600 1,748,020 
Total long-term borrowings and debt, net2,806,345 2,510,630 
Range of fixed interest rates on borrowings and debt in U.S. dollars
4.75% to 6.1%
4.75% to 6.15%
Range of floating interest rates on borrowings and debt in U.S. dollars
4.87% to 5.87%

4.80% to 5.66%
Range of fixed interest rates on borrowings and debt in Mexican pesos
9.20% to 10.78%
6.50% to 10.78%
Range of floating interest rates on borrowings and debt in Mexican pesos
7.14% to 7.81%
7.66% to 8.61%
Range of floating interest rates on borrowings and debt in Costa Rican colones
6.16%
6.28 %
Range of fixed interest rates on debt in Japanese yens
1.10% to 2.28%
0.95% to 1.90%
Range of fixed interest rates on debt in Euros
0.90% to 3.16%
0.90% to 3.16%
Range of fixed interest rates on debt in Australian dollars
6.81%
6.81 %
Range of fixed interest rates on debt in Sterling pounds
1.50%
1.50 %
Range of fixed interest rates on debt in Peruvian sol
7.00%
7.00 %
50

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
13.Borrowings and debt (continued)

Long-term borrowings and debt (continued)

The outstanding balances of long-term borrowings and debt by currency, excluding transaction costs, are as follows:

September 30,
2026
December 31,
2025
US dollar836,895 786,949 
Mexican peso1,740,795 1,480,905 
Japanese yen130,581 125,167 
Euro16,858 29,326 
Peruvian soles27,387 27,961 
Australian dollar9,580 9,599 
Sterling pound4,907 4,979 
Costa Rican colones27,492 25,175 
Carrying amount - principal2,794,495 2,490,061 
Future payments of long-term borrowings and debt outstanding as of September 30, 2026, are as follows:
YearOutstanding
202620,583 
2027874,968 
2028922,985 
2029899,160 
203019,000 
203148,219 
20349,580 
Carrying amount - principal2,794,495 























51

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
13.Borrowings and debt (continued)

Long-term borrowings and debt (continued)

The following table presents the reconciliation of movements of borrowings and debt arising from financing activities, as presented in the consolidated statement of cash flows:

20262025
Balance as of January 1,4,030,389 4,388,720 
Monetary transactions:
Net increase (decrease) in short-term borrowings and debt1,654,461 (609,454)
Proceeds from long-term borrowings and debt735,711 319,580 
Payments of long-term borrowings and debt(402,611)(866,901)
Non-monetary transactions:
Change in foreign currency rates(35,183)186,977 
Fair value adjustment due to hedge accounting relationship(4,456)10,841 
Other adjustments(431)2,003 
Liability-related
Interest expense(1)
179,197 179,187 
Interest paid(183,199)(184,139)
Balance as of September 30,5,973,878 3,426,814 
(1)Excludes the effect of derivatives hedging interest rate risk on Borrowings and debt, amounting to $32 million and $27 million as of September 30, 2026 and 2025, respectively.

14. Lease liabilities

Maturity analysis of contractual undiscounted cash flows of the lease liabilities is detailed below:
September 30,
2026
December 31,
2025
Up to 1 year
2,308 2,126 
From 1 to 5 years
8,803 8,134 
After 5 to 10 years
11,938 12,179 
Total undiscounted lease liabilities23,049 22,439 
Short-term1,596 1,461 
Long-term17,366 16,968 
Total lease liabilities included in the consolidated statement of financial position18,962 18,429 
Amounts recognized in the consolidated statement of cash flows:
September 30,
20262025
Payments of lease liabilities1,136 852 
Amounts recognized in consolidated statement of profit or loss:
Three months ended September 30,Nine months ended September 30,
2026202520262025
Interest on lease liabilities(188)(178)(537)(539)

52

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
15. Other liabilities

Following is a summary of other liabilities:
September 30,
2026
December 31,
2025
Accruals and other accumulated expenses27,839 26,901 
Accounts payable13,574 8,751 
Unearned commissions5,558 1,443 
Unassigned commissions6,384 14,185 
Others83 83 
Total53,438 51,363 

16. Dividends and coupons declared

The following amounts were recognized as dividends declared to equity holders:
September 30,
20262025
Dividends per ordinary share77,503 69,761 
Coupons on other equity instruments15,000 — 
Total92,503 69,761 
At the Board of Directors’ meeting held on July 21, 2026, the payment of the second coupon on the Bank’s Additional Tier 1 (AT1) capital instruments of $7.5 million was approved, which was paid on September 18, 2026.


17. Earnings per share

The following table presents a reconciliation of profit and share data used in the basic earnings per share (“EPS”) computations for the dates indicated:

Three months ended September 30,Nine months ended September 30,
2026202520262025
(Thousands of U.S. dollars)
Profit for the period63,150 54,968 185,959 170,884 
Coupons payable on other equity instruments(7,500)— (15,000)— 
Profit for the period attributable to holders oof ordinary shares55,650 54,968 170,959 170,884 
(U.S. dollars)
Basic earnings per share1.48 1.48 4.56 4.60 
(Thousands of shares)
Weighted average of common shares outstanding applicable to basic EPS37,597 37,231 37,521 37,126 



53

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
18.Other non-financial income

The following details other non-financial income:

Fees and Commissions:
Three months ended September 30,Nine months ended September 30,
2026202520262025
Structured services3,910 1,905 14,898 14,284 
Letters of credit and guarantees9,626 8,858 26,459 23,400 
Credit commitments3,637 3,959 12,434 8,157 
Other commissions402 236 2,747 765 
Total fee and commission income17,575 14,958 56,538 46,606 
Fees and commission expense(1,276)(906)(3,774)(2,059)
Total16,299 14,052 52,764 44,547 
The following table present information the unearned commission that is expected to be recognized on the existing contracts:
September 30,
2026
Up to 1 year2,988 
From 1 to 2 years2,154 
More than 2 years416 
Total5,558 

Gain (loss) on financial instruments:
Three months ended September 30,Nine months ended September 30,
2026202520262025
Gain (loss) on financial instruments:
At amortized cost:
Gain on derecognition of loans at amortized cost— — — 105 
Gain (loss) on derecognition of securities at amortized cost— — 112 (541)
Total gain (loss) on derecognition of financial instruments at amortized cost— — 112 (436)
At fair value through profit or loss (FVTPL):
Realized gain on sale of loans at FVTPL26 405 26 1,500 
Realized gain on trading derivatives79 — 139 — 
Unrealized gain on trading derivatives2,519 644 4,076 671 
Total gain on financial instruments at FVTPL2,624 1,049 4,241 2,171 
At fair value through other comprehensive income (FVOCI):
Realized gain on sale of loans at FVOCI— 485 75 638 
Realized gain on sale of securities at FVOCI— 475 125 563 
Total gain on financial instruments at FVOCI— 960 200 1,201 
Gain (loss) on hedging positions and foreign exchange transactions347 (1,127)279 2,091 
Total gain on financial instruments2,971 882 4,832 5,027 
54

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
19.Business segment information

        The following table provides certain information regarding the Bank’s operations by segment:
Three months ended September 30, 2026Nine months ended September 30, 2026
CommercialTreasuryTotalCommercialTreasuryTotal
Interest income184,230 30,796 215,026 508,280 91,911 600,191 
Interest expense(150)(135,095)(135,245)(429)(376,496)(376,925)
Inter-segment net interest income(109,416)109,416 — (304,925)304,925 — 
Net interest income74,664 5,117 79,781 202,926 20,340 223,266 
Other income16,540 2,799 19,339 53,605 4,251 57,856 
Total income91,204 7,916 99,120 256,531 24,591 281,122 
Provision for credit losses(10,493)81 (10,412)(24,378)633 (23,745)
Operating expenses(20,192)(5,366)(25,558)(56,335)(15,083)(71,418)
Segment profit for period60,519 2,631 63,150 175,818 10,141 185,959 
September 30, 2026
Segment assets12,860,971 3,582,667 16,443,638 
Segment liabilities345,651 14,290,676 14,636,327 


Three months ended September 30, 2025Nine months ended September 30, 2025
CommercialTreasuryTotalCommercialTreasuryTotal
Interest income156,856 36,824 193,680 193680000474,533 102,998 577,531 
Interest expense(142)(126,111)(126,253)(431)(376,678)(377,109)
Inter-segment net interest income(96,721)96,721 — (295,423)295,423 — 
Net interest income59,993 7,434 67,427 178,679 21,743 200,422 
Other income15,276 74 15,350 47,675 2,671 50,346 
Total income75,269 7,508 82,777 226,354 24,414 250,768 
Provision for credit losses(6,495)13 (6,482)(16,752)35 (16,717)
Operating expenses(16,787)(4,540)(21,327)(49,979)(13,188)(63,167)
Segment profit for period51,987 2,981 54,968 159,623 11,261 170,884 
December 31, 2025
Segment assets9,327,239 3,430,570 12,757,809 
Segment liabilities188,470 10,867,813 11,056,283 

55

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
19.Business segment information (continued)

The following table shows the reconciliation of information by business segments:
Three months ended September 30,Nine months ended September 30,
2026202520262025
Profit for the period63,150 54,968 185,959 170,884 
September 30,
2026
December 31,
2025
Assets:
Assets from reportable segments16,443,638 12,757,809 
Other assets - unallocated36,335 28,584 
Total16,479,973 12,786,393 
Liabilities:
Liabilities from reportable segments14,636,327 11,056,283 
Other liabilities - unallocated53,438 51,363 
Total14,689,765 11,107,646 

20.Related party transactions


The total compensation paid to directors and the executives as representatives of the Bank amounted to:

Three months ended September 30,Nine months ended September 30,
2026202520262025
Expenses:
Compensation costs to directors1,033 791 2,751 1,803 
Compensation costs to executives1,237 8,385 8,883 14,373 
Compensation costs of Bank´s directors and executives include annual cash retainers and the cost of granted restricted stock and restricted stock units, as detailed in the Stock Incentive Plan.

21.Litigation

As of September 30, 2026, the Bank is involved in a legal proceeding in which a payment of approximately $3.5 million is being claimed. Such proceeding is ongoing and had not been resolved as of the date of these consolidated financial statements. Based on management’s assessment and the opinion of external legal counsel, it is not considered probable that the resolution of this proceeding will result in an outflow of economic resources for the Bank. Accordingly, no provision has been recognized in the consolidated financial statements in respect of this matter.







56

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22. Applicable laws and regulations
Liquidity index

Rule No. 2-2018 issued by the Superintendence of Banks of Panama (SBP) establishes that every general license or international license bank must guarantee, with a higher level of confidence, that it is in the position to face its intraday liquidity obligations in a period when liquidity pressure may affect the lending market. For that purpose, the SBP has established a short-term liquidity coverage ratio known as “Liquidity Coverage Ratio or LCR”. This ratio is measured through the quotient of two amounts, the first one corresponds to the high-quality liquid assets and the second one corresponds to the net cash outflows in 30 days.
As of September 30, 2026, and December 31, 2025, the minimum LCR to be reported to the SBP was 100%. The Bank´s LCR as of September 30, 2026 was 147.8% (December 31, 2025: 159.3%).

Rule No. 4-2008 issued by the SBP, establishes that every general license or international license bank must always maintain, a minimum balance of liquid assets equivalent to 30% of the gross total of its deposits in the Republic of Panama or overseas up to 186 days, counted from the reporting date. The formula is based on the following parameters:
Liquid assets
x 100 = X% (Liquidity index)
Liabilities (Deposits received)

The liquidity index reported by the Bank to the regulator as of September 30, 2026 was 39.7% (December 31, 2025: 60.7%).
Capital adequacy
The Banking Law in the Republic of Panama and Rules No. 01-2015, 03-2016 and 05-2023 require that the general license banks maintain a total capital adequacy index. The Bank's capital, in accordance with current banking regulations, is separated into Ordinary Primary Capital: which consists of paid-in capital in shares, excess paid-in capital, declared reserves, retained earnings, minority interest shares and other accumulated comprehensive income items, less regulatory adjustments; and Additional Primary Capital: which consists of instruments issued by the Bank or consolidated subsidiaries that meet the requirements for inclusion, issue premiums, less regulatory adjustments applicable to additional primary capital.
As of September 30, 2026, the capital adequacy index may not be less, at any time, than 10.5% (including the capital conservation buffer of 1.25% required for 2025, according to Rule No. 05-2023) of total assets and off-balance sheet irrevocable contingency transactions, weighted according to their risks; and ordinary primary capital plus conservation buffer that shall not be less than 7% of its assets and off-balance sheet transactions that represent an irrevocable contingency, weighted based on their risks; and a total primary capital plus conservation buffer that shall not be less than 8.5% of its assets and off-balance sheet transactions that represent an irrevocable contingency, weighted based on their risks.

Capital Conservation Calculation

As of July 2024, Rule No. 05-2023, issued by the Superintendency of Banks of Panama, came into force, which establishes rules on the creation of a capital conservation buffer, whose objectives are:
(i) ensure that banks accumulate reserves that can be used in case of incurring losses,
(ii) that banks do not fail to comply with the established minimum requirements, without considering the conservation buffer, in episodes of deterioration in solvency.

As established in the Rule, banking entities must establish a capital conservation buffer of 2.5%, (established in a phased manner starting with 0.50% as of July 1, 2024, 0.75% for July 1, 2025 and 1.25% for July 1, 2026) of risk-weighted assets (credit, market and operating), made up of capital ordinary primary and in addition to all the minimum regulatory capital requirements that are established, for which the total minimum regulatory capital will be 8.5% for 2024, 9.25% for 2025 and 10.5% for 2026, (before the modification of the Rule 8%).

The primary objectives of the Bank’s capital management policy are to ensure that the Bank complies with capital requirements imposed by local regulators and maintains strong credit ratings and healthy capital ratios to support its business and to maximize shareholder value.
57

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22.Applicable laws and regulations (continued)

The Bank manages its capital structure and adjusts it according to changes in economic conditions and the risk characteristics of its activities. To maintain or adjust the capital structure, the Bank may adjust the amount of dividend payment to shareholders, return capital to shareholders or issue capital securities.

No changes have been made to the objectives, policies and processes from previous periods. However, they are under constant review by the Board of Directors.
The information corresponding to the total capital adequacy index is as follows:
September 30,
2026
December 31,
2025
Ordinary primary capital, net of adjustments1,405,901 1,322,970 
Capital funds1,781,011 1,675,484 
Risk-weighted assets12,432,305 10,822,730 
Ordinary capital ratio11.3%12.2%
Ordinary capital total12.9%14.1%
Capital adequacy ratio14.3%15.5%

Leverage ratio

Article No. 17 of the Rule No. 1-2015 establishes the leverage ratio of a regulated entity by means of the quotient between the ordinary primary capital and the total exposure for non-risk-weighted assets inside and outside the consolidated statement of financial position as established by the SBP. For the determination of the exposure of off-balance-sheet transactions, the criteria established for credit and counterparty credit risk positions will be used. The exposure of the derivatives will be the fair value at which they are recorded in the Bank’s assets.
The leverage ratio cannot be lower, at any time, than 3%. The Bank will inform to SBP as often as the compliance with the leverage ratio is determined.
The table below presents the Bank´s leverage ratio in compliance with Article No.17 of Rule No. 1-2015:

September 30,
2026
December 31,
2025
Ordinary capital1,405,901 1,322,970 
Non-risk-weighted assets17,203,996 13,402,426 
Leverage ratio8.2%9.9%
Regulatory reserves
Below is a list of the regulatory reserves that the Bank maintains in accordance with the prudential standards of the SBP:
September 30,
2026
December 31,
2025
Dynamic provision177,135 154,538 
Regulatory reserve for individual credits4,814 4,555 
Total regulatory reserves181,949 159,093 
Credit risk coverage - dynamic provision
The SBP by means of Rule No. 4-2013, establishes the compulsory constitution of a dynamic provision in addition to the specific credit provision as part of the total provisions for the credit risk coverage.

58

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22. Applicable laws and regulations (continued)
The dynamic provision is an equity item forms part of regulatory capital but does not replace or offset the capital adequacy requirements established by the SBP. This allocation is restricted for dividend distribution purposes.
Methodology for the constitution of the regulatory credit reserve

The SBP by means of the General Resolution of Board of Directors SBP-GJD-0003-2013 of July 9, 2013, establishes the accounting methodology for differences that arise between the application of IFRS and the application of prudential regulations issued by the SBP; as well as the additional disclosures required to be included in the notes to the consolidated financial statements.
The parameters established in this methodology are the following:
–The calculations of accounting balances in accordance with IFRS and the prudential standards issued by the SBP will be carried out and the respective figures will be compared.
–When the calculation made in accordance with IFRS results in a higher reserve or provision for the bank compared to the one resulting from the use of the prudential standards issued by the SBP, the Bank will account the IFRS figures.
–When the impact of the use of prudential standards results in a higher reserve or provision for the Bank, the effect of the application of IFRS will be recognized in profit or loss, and the difference between IFRS calculation compared to the prudential standards calculation will be appropriated from retained earnings as a regulatory credit reserve. If the Bank does not have sufficient retained earnings, the difference will be presented as an accumulated deficit account.
–The regulatory credit reserve mentioned in paragraph 3 of this Rule may not be reversed against retained earnings as long as there are differences between IFRS and the prudential standards.
Considering that the Bank presents its consolidated financial statements under IFRS, specifically for its expected credit reserves under IFRS 9, the line "Regulatory credit reserve" established by the SBP has been used to present the difference between the application of the accounting standard used and the prudential regulations of the SBP to comply with the requirements of Rule No. 4-2013.
Capital reserve
In addition to capital reserves required by regulations, the Bank maintains a capital reserve of $95.2 million, which was voluntarily established. Pursuant to Article No. 69 of the Banking Law, reduction of capital reserves requires prior approval of SBP.

Regulatory reserve for individual credits
Article 27 of Rule No. 4-2013, as amended by Article 1 of Rule No. 11-2019, indicates that all loans classified as unrecoverable must be written off within a period of no more than one year. For corporate loans with real estate collateral, the bank will write off all loans classified as unrecoverable within a period of no more than two years, from the date on which it was classified in that category. After two years, if the Bank has not made the write-off, it must create a reserve in the equity account, through the appropriation of retained earnings against, which will be charged to the value of the loan net of the provisions already established, according to the percentages established in the following table:
Percentage applicable
Period
At the beginning of the third year
50%
At the beginning of the fourth year
50%
In accordance with the provisions of Rule No. 11-2019 and 4-2013, the Bank recognized regulatory provisions for individual loans for $4.8 million as of September 30, 2026 (December 31, 2025: $4.6 million).

59

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22.Applicable laws and regulations (continued)

Specific provisions
Rule No. 4-2013, modified by Rule No. 8-2014, states that the specific credit provisions are originated from the objective and concrete evidence of impairment. These provisions must be established for credit facilities classified according to the risk categories denominated as: special mention, substandard, doubtful, or unrecoverable, both for individual credit facilities as for a group of such facilities. In the case of a group, it corresponds to circumstances that indicate the existence of deterioration in credit quality, although individual identification is still not possible.

Banks must calculate and maintain at all times the amount of the specific credit provisions determined by the methodology specified in this Rule, which takes into account the balance owed of each credit facility classified in any of the categories subject to provision, mentioned in the paragraph above; the present value of each guarantee available in order to mitigate risk, as established by type of collateral; and a weighting table that applies to the net exposure balance subject to loss of such credit facilities.
Article No. 34 of this Rule establishes that all credits must be classified in the following five (5) categories, according to their default risk and loan conditions, and establishes a minimum reserve for each classification: normal 0%, special mention 20%, substandard 50%, doubtful 80%, and unrecoverable 100%.
If there is an excess in the specific credit provision, calculated in accordance with this Rule, compared to the provision calculated in accordance with IFRS, this excess will be accounted for as a regulatory credit reserve in equity and will increase or decrease with appropriations from/to retained earnings. The balance of the regulatory credit reserve will not be considered as capital funds for calculating certain ratios or prudential indicators mentioned in the Rule.
Based on the classification of risks, collateral and in compliance with SBP Rule No. 4-2013, the Bank classified the loan portfolio as follows:
September 30, 2026
NormalSpecial mentionSubstandardDoubtfulUnrecoverableTotal
Loans at amortized cost
Corporations7,368,131 22,744 45,009 20,000 10,107 7,465,991 
Financial institutions:
Private2,628,436 — — — — 2,628,436 
State-owned358,999 — — — — 358,999 
2,987,435 — — — — 2,987,435 
Sovereign969,743 — — — — 969,743 
Total11,325,309 22,744 45,009 20,000 10,107 11,423,169 
Loans at FVOCI
Corporations277,465 — — — — 277,465 
Financial institutions:
Private118,757 — — — — 118,757 
Sovereign502,071 — — — — 502,071 
Total898,293 — — — — 898,293 
Total loans12,223,602 22,744 45,009 20,000 10,107 12,321,462 
Specific Provision— 4,549 22,505 16,000 10,107 53,161 
Allowance for loan
losses under IFRS (*):40,193 4,582 20,995 17,806 7,292 90,868 





60

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22.Applicable laws and regulations (continued)

December 31, 2025
NormalSpecial mentionSubstandardDoubtfulUnrecoverableTotal
Loans at amortized cost
Corporations6,195,013 101,333 — 26,933 11,775 6,335,054 
Financial institutions:
Private2,401,466 — — — — 2,401,466 
State-owned250,036 — — — — 250,036 
2,651,502 — — — — 2,651,502 
Sovereign118,169 — — — — 118,169 
Total8,964,684 101,333 — 26,933 11,775 9,104,725 
Loans at FVOCI
Corporations52,261 — — — — 52,261 
Financial institutions:
Private19,363 — — — — 19,363 
State-owned4,952 — — — — 4,952 
24,315 — — — — 24,315 
Total76,576 — — — — 76,576 
Total loans9,041,260 101,333 — 26,933 11,775 9,181,301 
Specific Provision— 20,267 — 21,546 7,220 49,033 
Allowance for loan
losses under IFRS (*):34,406 30,891 — 20,126 8,853 94,276 

As of September 30, 2026 the restructured loans are $15.3 million, (December 31, 2025: the restructured loans are for $51.2 million).
Rule No.4-2013 defines as Past Due any credit facility for which payment of contractually agreed amounts present more than thirty (30) days in arrears, up to ninety (90) days; and as Delinquent, any credit facility for which payment of contractually agreed amounts present more than ninety (90) days in arrears, except for single-payment transactions and overdrafts, which will be considered Delinquent when payment exceeds thirty (30) days in arrears from the contractual payment date.










61

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22.Applicable laws and regulations (continued)
Below is the classification of the loan portfolio by maturity profile based on Rule No. 4-2013 and modified by Rule No. 8-2014:
September 30, 2026
CurrentPast dueDelinquentTotal
Loans at amortized cost
Corporations7,435,884 — 30,107 7,465,991 
Financial institutions:
Private2,628,436 — — 2,628,436 
State-owned358,999 — — 358,999 
2,987,435 — — 2,987,435 
Sovereign969,743 — — 969,743 
Total11,393,062 — 30,107 11,423,169 
Loans at FVOCI
Corporations277,465 — — 277,465 
Financial institutions:
Private118,757 — — 118,757 
Sovereign502,071 — — 502,071 
Total898,293 — — 898,293 
Total loans12,291,355 — 30,107 12,321,462 

December 31, 2025
CurrentPast dueDelinquentTotal
Loans at amortized cost
Corporations6,298,014 20,000 17,040 6,335,054 
Financial institutions:
Private2,401,466 — — 2,401,466 
State-owned250,036 — — 250,036 
2,651,502 — — 2,651,502 
Sovereign118,169 — — 118,169 
Total9,067,685 20,000 17,040 9,104,725 
Loans at FVOCI
Corporations52,261 — — 52,261 
Financial institutions:
Private19,363 — — 19,363 
State-owned4,952 — — 4,952 
Total76,576 — — 76,576 
Total loans9,144,261 20,000 17,040 9,181,301 






62

Bladex, Inc. and Subsidiaries
Notes to the unaudited interim condensed consolidated financial statements
(Amounts expressed in thousands of U.S. dollars, unless otherwise indicated)
22.Applicable laws and regulations (continued)
In accordance with Rule No. 4-2013, as amended by Rule No. 8-2014, non-accruing loans are presented by category as follows:    
September 30, 2026
NormalSpecial mentionSubstandardDoubtfulUnrecoverableTotal
Loans at amortized cost
Impaired loans— — 45,009 20,000 10,107 75,116 
Total— — 45,009 20,000 10,107 75,116 
December 31, 2025
NormalSpecial mentionSubstandardDoubtfulUnrecoverableTotal
Loans at amortized cost
Impaired loans— — — 26,933 11,775 38,708 
Total— — — 26,933 11,775 38,708 

September 30,
2026
December 31,
2025
Non-accruing loans:
Private corporations75,116 38,708 
Unrecognized interest on non-accrual loans5,338 1,302 
As of September 30, 2026, and December 31, 2025, there was no interest income collected on loans in non-accrual status.

23.Subsequent events
Dividends declared
At a meeting of the Board of Directors held on October 20, 2026, the declaration of a quarterly cash dividend of US$0.6875 per common share, corresponding to the third quarter of 2026, was approved. The dividend will be paid on November 20, 2026 to holders of the Bank’s common shares of record as of November 06, 2026.



63